Skip to main content
PLOS One logoLink to PLOS One
. 2024 Mar 6;19(3):e0297326. doi: 10.1371/journal.pone.0297326

Systematic review of social determinants of childhood immunisation in low- and middle-income countries and equity impact analysis of childhood vaccination coverage in Nigeria

Sarah V Williams 1,*, Tanimola Akande 2, Kaja Abbas 3,4
Editor: Harapan Harapan5
PMCID: PMC10917251  PMID: 38446836

Abstract

Background

Nigeria has a high proportion of the world’s underimmunised children. We estimated the inequities in childhood immunisation coverage associated with socioeconomic, geographic, maternal, child, and healthcare characteristics among children aged 12–23 months in Nigeria using a social determinants of health perspective.

Methods

We conducted a systematic review to identify the social determinants of childhood immunisation associated with inequities in vaccination coverage among low- and middle-income countries. Using the 2018 Nigeria Demographic and Health Survey (DHS), we conducted multiple logistic regression to estimate the association between basic childhood vaccination coverage (1-dose BCG, 3-dose DTP-HepB-Hib (diphtheria, tetanus, pertussis, hepatitis B and Haemophilus influenzae type B), 3-dose polio, and 1-dose measles) and socioeconomic, geographic, maternal, child, and healthcare characteristics in Nigeria.

Results

From the systematic review, we identified the key determinants of immunisation to be household wealth, religion, and ethnicity for socioeconomic characteristics; region and place of residence for geographic characteristics; maternal age at birth, maternal education, and household head status for maternal characteristics; sex of child and birth order for child characteristics; and antenatal care and birth setting for healthcare characteristics. Based of the 2018 Nigeria DHS analysis of 6,059 children aged 12–23 months, we estimated that basic vaccination coverage was 31% (95% CI: 29–33) among children aged 12–23 months, whilst 19% (95% CI:18–21) of them were zero-dose children who had received none of the basic vaccines. After controlling for background characteristics, there was a significant increase in the odds of basic vaccination by household wealth (AOR: 3.21 (2.06, 5.00), p < 0.001) for the wealthiest quintile compared to the poorest quintile, antenatal care of four or more antenatal care visits compared to no antenatal care (AOR: 2.87 (2.21, 3.72), p < 0.001), delivery in a health facility compared to home births (AOR 1.32 (1.08, 1.61), p = 0.006), relatively older maternal age of 35–49 years compared to 15–19 years (AOR: 2.25 (1.46, 3.49), p < 0.001), and maternal education of secondary or higher education compared to no formal education (AOR: 1.79 (1.39, 2.31), p < 0.001). Children of Fulani ethnicity in comparison to children of Igbo ethnicity had lower odds of receiving basic vaccinations (AOR: 0.51 (0.26, 0.97), p = 0.039).

Conclusions

Basic vaccination coverage is below target levels for all groups. Children from the poorest households, of Fulani ethnicity, who were born in home settings, and with young mothers with no formal education nor antenatal care, were associated with lower odds of basic vaccination in Nigeria. We recommend a proportionate universalism approach for addressing the immunisation barriers in the National Programme on Immunization of Nigeria.

Introduction

Nigeria is the most populous country in Africa with around 202 million people in 2020 and its population is predicted to double by 2050 [1]. It is a multi-ethnic country with 36 autonomous states and the Federal Capital Territory. Around 83 million people (40% of total population) live below the poverty line while an additional 53 million people (25% of total population) are vulnerable to falling below the poverty line [2]. Economic growth has been slow with challenges including ongoing conflict in parts of the country, inconsistent regulatory environment, poor power supply and infrastructure [2].

Vaccination is a highly cost-effective public health intervention and beyond the direct benefits to population health, vaccines provide additional economic and social benefits to individuals and society [3, 4]. Infectious diseases remain a leading cause of death among under-5-year-old children, and an additional 1.5 million deaths could be avoided every year with improvements in global vaccination coverage [5, 6]. Model-based estimates, not including COVID-19, project 51 million deaths to be prevented by vaccination during 2021–2030 [7]. There have been substantial improvements in vaccine introductions and vaccination coverage in low- and middle-income countries since the inception of Gavi, the Vaccine Alliance in 2000 [8]. However, the prevalence of zero-dose children, that is children aged 12–23 months who had not received any of the routine childhood vaccines, was 7.7% in low- and middle-income countries during 2010–2019 [9]. The importance of improving vaccination coverage was recognised in the Sustainable Development Goals (SDGs), with immunisation contributing to 14 of the 17 SDGs and includes reduction on poverty, hunger and improving social equity [10]. Vaccination coverage and equity are a strategic goal of the global Immunisation Agenda 2030, with the aim to reach equitable coverage at national and district levels by addressing immunisation barriers posed by location, age, socioeconomic status, and gender [11].

The Expanded Programme on Immunisation (EPI) was established by the World Health Organization (WHO) in 1974 to improve vaccination services globally [12], and Nigeria began nationwide implementation of EPI in 1979 which was later changed to the National Programme on Immunization [13]. Although the vaccines in the routine immunisation programme (S1 Table) for under 5-year-old children are available with no out-of-pocket charges [14], Nigeria has the most under-immunised children in the world with 4.5 million in 2018 [15]. The immunisation system challenges in Nigeria include weak institutions, service delivery, funding, infrastructure, poor coordination between the National Programme on Immunization and non-governmental organisations delivering vaccination services, and a lack of political commitment in some regions, with further challenges to immunisation services caused by the COVID-19 pandemic [14, 1618]. There are fewer adequately skilled healthcare personnel in rural areas and northern states, and poor retention and frequent transfers of workers. Security is also an issue, with attacks on healthcare workers in recent years. Attitudes of communities and caregivers are important too, with a lack of knowledge about vaccination and mistrust of services hindering vaccination uptake [16, 19].

In the context of wider immunisation system challenges in Nigeria, we focused on factors associated with inequities in basic vaccination coverage through the social determinants of health model. This model framework has been explicitly linked to health equity by the WHO Commission on Social Determinants of Health [20] and considers the social, cultural, political, economic, commercial and environmental factors that shape the conditions in which people are born, grow, live, work and age, and these factors are determined by wealth, power and resources. In this study, we use the social determinants of health model framework, which encompasses the individual, parental, household, environment, and national policy levels that influence inequities in basic vaccination coverage among children in Nigeria (see Fig 1). We refer to vaccine inequity as unfair and avoidable or remediable differences in health among population groups defined socially, economically, demographically, or geographically [21]. This is related to but distinct from health inequality, which indicates the status of imbalances or differences in health among population groups without any moral judgement on whether the imbalances or differences are fair or not [22, 23].

Fig 1. Social determinants of childhood immunisation.

Fig 1

Social determinants of health model framework encompassing the individual, parental, household, environment, and national policy levels and influencing inequities in basic vaccination coverage among children in Nigeria.

Our aim is to analyse the 2018 Nigeria Demographic and Health Survey (DHS) and estimate the inequities in basic vaccination coverage (1-dose BCG (Bacille Calmette-Guérin), 3-dose DTP-HepB-Hib (diphtheria, tetanus, pertussis (DTP), hepatitis B (HepB) and Haemophilus Influenzae type b (Hib)), 3-dose polio, and 1-dose measles vaccines) associated with socioeconomic, geographic, maternal, child, and healthcare characteristics among children aged 12–23 months in Nigeria. We conducted disaggregated equity impact analysis to reveal the inequities in basic vaccination coverage that are hidden at the aggregated national level, and understand the facilitators and barriers to vaccination through the social determinants of health framework.

Methods

Study design of demographic and health survey

We analysed the 2018 Nigeria DHS which was conducted between August to December 2018 [24]. The DHS are nationally representative household surveys focusing on population, health, and nutrition in LMICs [25]. The DHS sample is a two-stage stratified cluster sample with sampling weights applied to ensure that results are representative. There are four questionnaires: household questionnaire, woman’s questionnaire, man’s questionnaire, and biomarker questionnaire. The country is divided into clusters with 30 households selected from each cluster. The woman’s questionnaire was asked to women aged 15–49 years and provides the data for our study. All women aged 15–49 years in the sampled households were included and the survey was successfully conducted in 1,389 clusters after 11 clusters were dropped following deteriorating security in those areas during data collection. In addition, in the state of Borno, 11 of the 27 Local Government Areas (LGAs) in the state were dropped due to insecurity. Clusters selected from these dropped LGAs were replaced with clusters from the remaining LGAs and so may not be representative of the entire state [24]. The study population for our analysis was women aged 15–49 years with a child aged 12 to 23 months old. Of the 41,821 women interviewed, 33,924 women had a child aged 59 months or younger and immunisation data was collected for 6,059 living children aged between 12–23 months. We applied sampling weights to the survey dataset to adjust for disproportionate sampling and non-response, thereby ensuring that the sample was representative of the population.

Characteristics selection and systematic review

The WHO had analysed inequality in immunisation using the following characteristics determined from a literature review: child (gender, birth order), maternal (age at birth, education, ethnicity or caste), household (sex of household head, household economic status), geographic (rural or urban place of residence, subnational region) [26]. Using the WHO inequality work as a starting point, we conducted a systematic review to select the pertinent DHS variables for our equity analysis. We conducted a systematic review to analyse qualitative and quantitative peer-reviewed literature of studies focused on inequities in childhood immunisation in low- and middle-income countries (LMICs) to identify the social determinants of childhood immunisation. S1 Fig illustrates the process flow diagram of identification, screening, eligibility, and inclusion of articles for the systematic review, using the PRISMA (Preferred Reporting Items for Systematic Reviews and Meta-Analyses) framework (S1 Checklist) [27]. We conducted our search using MEDLINE and additional studies were identified through hand-searches of reference lists for articles written in the English language, published between 01/01/2010 to 04/10/2021, for which the full text was available, and contained the following terms in English or American spellings: (Vaccination coverage or Immunisation coverage) AND (Determinant, characteristic, predictor) AND (Equity, equality, disparity, inequality, inequity). We did not search prior to 2010 as papers and the subsequently identified social determinants may be less relevant to the current context.

Vaccination coverage

In the 2018 Nigeria DHS, the information of whether a child has received a vaccination is gathered from the child’s vaccination card. If that is not available or if a vaccine has not been recorded, then the mother is asked which vaccines have been given to her child [24]. Our primary outcome and dependent variable of interest was basic vaccination coverage, that is the proportion of children receiving 1-dose BCG, 3-dose DTP-HepB-Hib, 3-dose polio, and 1-dose measles vaccines. DHS gives the vaccination status of “received” and “not received” for individual vaccines. Binary variables of “received all three doses” and “not received all three doses” were generated for the three dose vaccines. The basic vaccination variable was generated as a binary variable of “received all basic vaccinations” and “not received all basic vaccinations” by combining the variables for 1-dose BCG, 3-dose DTP-HepB-Hib, 3-dose polio, and 1-dose measles vaccines.

Equity analysis

We conducted simple logistic regression to estimate crude odds ratios and assess basic vaccination coverage disaggregated by socioeconomic, geographic, maternal, child, and healthcare characteristics as measured by the DHS and identified through the systematic review and the WHO inequality report on immunisation [26]. Due to the survey design, a p-value for all categories within a characteristic was determined using the Adjusted Wald’s test through the “test” function in Stata [28]. These p-values were used to assess the association between basic vaccination coverage and the characteristics [29] and if a p-value was <0.05 then the characteristic was included in the model. We checked for collinearity between variables and avoided multicollinearity in the development of a parsimonious model [29] using the “regress” in Stata and calculation of the variance inflation factor. However, no variables required removal from the model.

Interaction was tested using the “contrast” function in Stata. This gives F statistics which are adjusted for the survey design, with the p-value demonstrating the statistical significance of the interaction. As in the WHO report [26, 29], interactions were tested between mother’s education and household wealth, mother’s age and household wealth, mother’s age and education, and place of residence and household wealth. We conducted multivariable logistic regression to estimate adjusted odds ratios (AORs) for socioeconomic, geographic, maternal, child, and healthcare characteristics associated with basic vaccination coverage.

We analysed inequity further by estimating the Erreygers concentration indices for maternal education, antenatal care, and household wealth to assess if basic vaccination coverage and vaccination card usage had progressive, regressive, or equal distribution based on each of these characteristics. The concentration index value shows how much of a health measure is concentrated in an advantaged or disadvantaged group. Values range from +1 to -1, with a value of zero meaning there is no inequity and positive values indicating that a health measure is concentrated in the more advantaged groups [30].

Reproducibility of analysis

We conducted the survey analysis using the Stata statistical software [28], and visualisations were generated using the R statistical software [31].

Results

In the systematic review, we identified 160 publications, screened the title and abstract, assessed full articles for eligibility, and included 49 publications in our systematic review (see Table 1). In addition to the characteristics analysed by the WHO inequality report on immunisation [26], we identified that antenatal care and birth setting had evidence of association with vaccination coverage. We streamlined the social determinants of childhood immunisation to: household wealth, religion, and ethnicity for socioeconomic characteristics; region and place of residence for geographic characteristics; maternal age at birth, maternal education, and maternal household head status for maternal characteristics; sex of child and birth order for child characteristics; and antenatal care and birth setting for healthcare characteristics.

Table 1. Systematic review of social determinants of childhood immunisation.

Location Key inferences Source
Afghanistan Approximately 60% of children aged 1–4 years were under vaccinated or not vaccinated, with large disparities among provinces and higher coverage in urban areas. Increased odds of full immunisation were associated with giving birth in government institution, having a higher number of antenatal care visits, and visiting a health facility in the past 12months. Maternal involvement in household decision making was also significantly associated with vaccination status. Shenton et al., 2018 [32]
Angola In Bom Jesus in Angola, 37% of under 5-year-old children had completed the vaccination schedule, but coverage was higher for under 1-year-old children. Coverage was higher in rural areas. The percentage of children completing the vaccination schedule varied according to child age, mother’s education, family size, ownership of household appliances, and means of disposal of domestic waste. Oliveira et al., 2014 [33]
Bangladesh There was no significant disparity of vaccination coverage by ethnicity. There was significant variation of vaccination coverage by the child’s gender (lower for females), household ownership of mobile phones and by household geographical location. Rahman et al., 2018 [34]
Bangladesh Maternal age, education and wealth have a significant effect on coverage of most vaccines. The number of microfinancing organisations in the community also increased the odds of children being vaccinated, whilst poor accessibility or being far from a health centre, specifically an Upazilla Health Complex, decreased the odds of a child being vaccinated. There are differences between regions, but even in regions with relatively higher coverage, some communities had poor coverage. Vyas et al., 2019 [35]
Cameroon Analysis of five rounds of DHS surveys from 1991 to 2001 showed that children in the latter rounds were more likely to be fully immunised. The likelihood of children being fully immunised was affected by having a vaccination card, birth order, maternal age and maternal education. Nda’chi Deffo et al., 2020 [36]
Democratic Republic of the Congo In urban areas, children of educated mothers had higher measles vaccination coverage in comparison to children of mothers with no formal education. In rural areas, children of wealthier households had higher measles vaccination coverage. Vaccination card usage rates were higher in urban areas than rural areas. Ashbaugh et al., 2018 [37]
Ethiopia Around 25% of children aged 12–23 months were fully vaccinated and coverage varied with urbanicity. Predictors of full coverage were sources of information from the vaccination card, received postnatal check-up within two months after birth, region, women’s awareness of community conversation program, and wealth index. Lakew et al., 2015 [38]
Ethiopia Children from poorer households, rural regions of Afar and Somali, no maternal education, and female-headed households had lower full vaccination coverage. Geweniger et al., 2020 [39]
Ghana Vaccination coverage at the end of the first year of life was high except for polio vaccine given at birth. However, many vaccines were given late and there was substantial health inequity across socioeconomic indicators for timeliness of vaccination. Gram et al., 2014 [40]
India Slightly more than half of children aged 12–36 months were fully vaccinated in 2008. The analysis adjusted for state of residence, age, gender, household wealth, and maternal education, and other predictors of vaccination were religion, caste, place of delivery, number of antenatal care visits, and maternal tetanus vaccination. Children in urban areas had higher odds of being unvaccinated or under-vaccinated than those in rural areas. Shrivastwa et al., 2015 [41]
India Vaccine coverage in an urban poor area of south east Delhi was lower than estimates from other studies for overall regional urban coverage, indicating a discrepancy in coverage between the urban poor and urban non-poor. Coverage was determined by gender of child, religion, maternal literacy, household’s socioeconomic position, being born in a facility and being born outside of Delhi and having a birth certificate. Devasenapathy et al., 2016 [42]
India There were regional disparities in vaccination coverage with a north south divide. All doses of vaccination coverage were significantly associated with postnatal care, institutional births, neonatal tetanus protection of the last birth, women’s education, and health insurance coverage Khan et al., 2018 [43]
India Approximately 50% of children aged 12–23 months were fully vaccinated in a pooled dataset of three time periods (1998–99, 2002–04 and 2007–08), and children recorded in the 2007–08 dataset were more likely to be vaccinated. Vaccination was inversely associated with female gender, Muslim religion, lower caste, urban residence, and maternal characteristics (lower educational attainment, non-institutional delivery, fewer antenatal care visits and non-receipt of maternal tetanus vaccination). The most common reason for non-vaccination was that mothers were unaware of the need. Francis et al., 2018 [44]
India Immunisation was highly associated with maternal education and household wealth. Inequality in immunisation was highest in lower socioeconomic groups among children of mothers with no formal education. Kannankeril Joseph VJ et al., 2021 [45]
India Full immunisation was associated with living in urban areas and richer household wealth, and was highest in Manipur and lowest in Nagaland. Srivastava et al., 2021 [46]
Indonesia Immunisation was significantly associated with birth order, maternal age, maternal education, paternal occupation, antenatal care, and living in certain regions. Being resident in communities with a higher proportion of public health centres were more likely to be fully immunised. Siramaneerat et al., 2021 [47]
Kenya Measles vaccination coverage differed according to household wealth, parents’ education, skilled antenatal care visits, birth order and father’s occupation. Rural residence reduced inequality in measles vaccination, which may reflect efforts to provide vaccination sites in remote and rural areas of the country. Van Malderen et al., 2013 [48]
Kenya Birth setting, ethnicity, and wealth index were significant predictors of vaccination coverage. Somalis had greater odds of being under or non-vaccinated than the Kikuyu ethnic group, and wealth and birth setting were associated with immunisation status for both Somalis and non-Somalis. Masters et al., 2019 [49]
Kenya Children of mothers with no education, born in home settings, in regions with limited health infrastructure, living in poorer households, and of higher birth order are associated with lower rates of full immunisation. Allan et al., 2021 [50]
Kenya Immunisation coverage and timeliness of immunisation improved during 2003–2017. In two urban informal settlements, the hazard for being fully immunised varied by household wealth and ethnicity. Mutua et al., 2020 [51]
Laos Community demand for immunisation was lowered by health system barriers of multiple providers, inconsistent record keeping, and inadequate health information system. Lack of understanding of the value of vaccination and immunisation services was demonstrated at the individual and household levels. Sychareun et al., 2019 [52]
Malawi There were regional differences in vaccination coverage and regions with higher coverage had a high percentage of deliveries attended by a health professional. Coverage was higher for women who gave birth at a hospital or maternity clinic or had a midwife or nurse at birth. Coverage was significantly correlated with some socio-demographic characteristics: child’s age, illiteracy, income, water, and sanitary conditions. Abebe et al., 2012 [53]
Malawi In children aged 12–23 months, individual factors had a stronger effect than community factors on vaccination coverage. Mother’s education, frequency of antenatal care visits, use of immunisation cards, household wealth, and geographical region were the most significant factors associated with vaccination coverage. Ntenda et al., 2017 [54]
Mozambique Analysis of data from the 2015 Immunization, AIDS and Malaria Indicators Survey (IMASIDA), indicated that living in the Southern region was a protective factor for full immunisation whilst being in the poorest quintile increased the risk of a child not being fully immunised. Daca et al., 2020 [55]
Nepal A quarter of children were not fully immunised. Full immunisation was associated with having an immunisation card, delivery in a public or private institution, maternal education and maternal employment. Patel et al., 2021 [56]
Nigeria Socio-economic characteristics explained the disparities in full vaccination and recommended community-level interventions focused on improving full vaccination coverage. Antai, 2009 [57]
Nigeria Women who were sole providers of household earnings were associated with higher likelihood of fully immunising their children, while women who lack decision-making autonomy were associated with lower likelihood of fully immunising their children. Antai, 2012 [58]
Nigeria Routine immunisation data shows lower coverage in states of northern Nigeria compared with states of southern Nigeria. When comparing determinants of supply side access in two northern and two southern states, regional supply-side disparities were not apparent. However, there was a general sub-optimal supply of services and residents in the northern states were more likely to live within 5km of an immunisation service. This supports socio-cultural explanations of disparities in immunisation coverage. Eboreime et al., 2015 [59]
Nigeria Fully immunised children are concentrated amongst the rich and partially immunised children are concentrated amongst the poor, no significant difference between socioeconomic status for unimmunised. Concentration of fully immunised children among the rich were determined by mother’s literacy, living in the rural area, socioeconomic status and geopolitical location. Significant concentration of partially immunised children among the poor were determined by the same factors. Ataguba et al., 2016 [60]
Nigeria In a cross-sectional study in south-eastern Nigeria of under 5-year-old children, vaccination coverage was poor and below national targets. There were differences in coverage between wealth quartiles with the wealthiest having higher coverage than the poorest. Coverage was highest for children in the first year of life and decreased with age. Uzochukwu et al., 2017 [61]
Nigeria Children being unvaccinated against polio was significantly associated with household wealth index, maternal educational level, maternal employment, geopolitical and neighbourhood illiteracy level. Uthman et al., 2017 [62]
Nigeria Coverage varied by place of residence (rural, urban formal, and urban slum) and was significantly associated with place of delivery, antenatal care, maternal education, maternal age at childbirth, religion, place of residence, media exposure and distance to a health facility. Population attributable risk analysis demonstrated the biggest increase in coverage for maternal education and biggest reduction for non-attendance at antenatal care. Obanewa et al., 2020 [63]
Pakistan Vaccination coverage of children aged 12–23 months was strongly associated with maternal education, paternal education, extended family structure and family wealth. Coverage differed by ethnicity, with Bengali children having the lowest coverage. Siddiqui et al., 2014 [64]
East African countries Most children in each country had received one of the recommended vaccinations, with regional variation within countries. There were no consistent predictors across countries of complete vaccination status. However, being delivered in a public institution rather than at home was associated with increased odds, except in Burundi. Whether a child had received a check-up within two months of birth was also associated with complete vaccination status in Burundi, Kenya, and Uganda. Canavan et al., 2014 [65]
West Africa Vaccination coverage increased between 2000 and 2017. Inequalities in coverage were mainly related to poverty, maternal education and living in certain regions. Wariri et al., 2019 [66]
Sub-Saharan Africa Poor households were more likely to have missed opportunities for vaccination. In some countries, literacy, maternal education, media access and the number of under 5-year-old children contributed to missed opportunities for vaccination. Ndwandwe et al., 2018 [67]
Sub-Saharan Africa Education inequality in missed opportunities for vaccination was mainly explained by differential effects such as neighbourhood socioeconomic status, presence of under 5-year-old children, media access and household wealth index. Sambala et al., 2018 [68]
Sub-Saharan Africa Vaccination coverage was lower in rural areas and household wealth, birth order and distance to health facilities were important contributors to the rural-urban gap. Ameyaw et al., 2021 [69]
Conflict-impacted countries In conflict affected countries, low vaccination coverage and outbreaks of vaccine preventable diseases are a concern. Many outbreaks were in conflict-affected areas or in displaced populations. In 14 of the 16 conflict affected countries, DTP3 coverage was below the global average of 85% in 2014. Grundy et al., 2019 [70]
Gavi-supported countries Following a systematic analysis of inequalities in vaccination coverage in 45 Gavi supported countries, recommendations were made for Gavi equity monitoring. In addition to the wealth index, other measures of vulnerability should be monitored: maternal education, place of residence, child sex and the multidimensional poverty index. Both absolute and relative measures should be tracked. Arsenault et al., 2017 [71]
Gavi-supported countries DHS data from 45 Gavi supported countries demonstrated that vaccination coverage and inequalities varied between countries. There were wealth, education, and multidimensional poverty index (MPI) inequalities in vaccination coverage. Country level predictors of vaccination coverage included political stability, government expenditure on health, government effectiveness and control of corruption, greater land area, linguistic fractionalisation, and gender inequality. There were similar associations across the three indicators of inequality (wealth, maternal education and multidimensional poverty) for country level predictors of inequality. Arsenault et al., 2017 [72]
Low- and middle-income countries By analysing data from 241 nationally representative household surveys in 96 countries, being unvaccinated was strongly associated with education of the caregiver, education of caregiver’s partner, caregiver’s tetanus toxoid status, wealth index and type of family member participation in decision-making when the child is ill. Tetanus toxoid status was the strongest predictor of unvaccinated status. Bosch-Capblanch et al., 2012 [73]
Low- and middle-income countries Twenty-five studies were reviewed to assess the relevance of gender inequality on the structural, health system, community, and individual levels. Vaccination programmes often target mothers and can therefore reinforce a community’s gender and social dynamics, with women facing barriers at every level to accessing vaccinations: access to education, income, as well as autonomous decision-making about time and resource allocation were evident barriers. Merten et al., 2015 [74]
Low- and middle-income countries The greatest disparities were among children born to women with no formal education compared to children born to women with secondary or higher education. Coverage was lower in rural areas compared to urban areas and in the lowest wealth quintile compared to the richest quintile. No gender differences were observed. Hinman et al., 2015 [75]
Low- and middle-income countries Rural-urban migrant children were less likely to be immunised than urban non-migrants and the general population. Coverage estimates were lower for most vaccines for rural-urban migrants than for the general population. Awoh et al., 2016 [76]
Low- and middle-income countries Vaccination coverage varied between and within countries, and coverage was lowest in children from poorer households with pro-rich inequality in most countries. Hosseinpoor et al., 2016 [77]
Low- and middle-income countries In most countries, vaccination coverage was pro-rich, and coverage was higher in urban areas than rural areas. Antenatal care was concentrated among wealthier mothers and was significantly associated with the concentration of vaccination coverage among wealthier children. Hajizadeh et al., 2018 [78]
Low- and middle-income countries The WHO analysed inequality in immunisation using the following characteristics determined from a literature review: child (gender, birth order), maternal (age at birth, education, ethnicity or caste), household (sex of household head, household economic status), geographic (place of residence—rural or urban, subnational region). The analysis focused on ten countries that account for more than 70% of children globally who did not receive basic vaccination. WHO, 2018 [26]
Low- and middle-income countries DHS data was examined for socioeconomic inequalities in the completion rates of vaccines in the Gambia, the Kyrgyz Republic and Namibia. Higher completion of vaccination was observed in rural areas. Completion rate for BCG, DTP3, polio (3-doses), and measles vaccines had a pro-poor distribution with children of lower socioeconomic status more likely to be immunised than children from higher socioeconomic status. In the Gambia and Namibia, the difference in completion rates for childhood immunisation between rural and urban areas was the primary contributor for the concentration of child vaccination among the poor. In the Kyrgyz Republic, household wealth was a key determinant for child vaccination. Birth order, maternal age, maternal education, and skilled birth attendance were also factors in some of the countries. Hajizadeh,. 2019 [79]

Systematic review of studies focused on inequities in childhood immunisation in low- and middle-income countries.

Vaccination coverage

Among the 6,059 children aged 12–23 months in the 2018 Nigeria DHS following the application of sample weights, 2,100 (35%) of them lived in urban areas. The coverage for the individual vaccines of BCG, DTP-HepB-Hib, polio, and measles was higher in urban areas compared to rural areas (Fig 2 and S2 Table). At the national level, the mean basic vaccination coverage was 31% (95% CI: 29–33) with coverage of single vaccinations ranging from 48% (46–50%) for the third dose of the polio vaccine to 73% (71–75%) for the first dose of the polio vaccine.

Fig 2. Vaccination coverage and vaccination card usage rates in Nigeria.

Fig 2

Vaccination coverage among children aged 12–23 months in Nigeria and disaggregated by urban and rural areas of residence. Vaccination card coverage is relatively higher in urban areas in comparison to rural areas, and is associated with higher vaccination coverage. Basic vaccination includes 1-dose BCG (Bacille Calmette-Guérin), 3-dose DTP-HepB-Hib (diphtheria, tetanus, pertussis, hepatitis B and Haemophilus influenzae type B), 3-dose polio, and 1-dose measles vaccines.

Vaccination cards were available for 49% (46–51%) of children, among which 57% (55–60%) had received all basic vaccinations. Among the 51% (49–54%) of children without vaccination cards, only 6.4% (5.3–7.7%) of them had received all basic vaccinations. Almost one fifth of children (19% (18–21%)) had not received any of the basic vaccinations and in rural areas almost a quarter had received none. For polio vaccinations, 26% (24–28%) of children had received none of the three doses and for DTP vaccinations, 35% (33–37%) of children had received none. There was a higher proportion of zero-dose children in rural areas compared to urban areas.

Equity analysis

Fig 3 shows the basic vaccination coverage among children aged 12–23 months in Nigeria disaggregated by socioeconomic (household wealth, religion, ethnicity), geographic (region, place of residence), maternal (maternal age at birth, maternal education, maternal household head status), child (sex of child, birth order), and healthcare (antenatal care, birth setting) characteristics. For socioeconomic characteristics, children living in wealthier households had higher basic vaccination coverage ranging from 17% (15–20%) to 49% (45–53%) from the poorest to the richest wealth quintiles. For religion, basic vaccination coverage was higher among children of the Catholic faith at 49% (43–54%) while most children (58%) were of Islamic faith with relatively lower coverage of 23% (21–25%). Regarding ethnicity, basic vaccination coverage ranged from 12% (9–16%) to 56% (51–61%) among children of Fulani and Igbo ethnicities respectively. For geographic characteristics, 65% of children lived in rural areas but basic vaccination coverage was higher for children in urban areas at 44% (41–47%) in comparison to 23% (21–25%) in rural areas. At the regional level, basic vaccination coverage among children ranged from 20% (17–23%) in the North West region to 57% (51–62%) in the South East region (Fig 4). For maternal characteristics, children of mothers aged 35–49 years had higher basic vaccination coverage at 34% (31–39%) in comparison to 16% (12–21%) for children of younger mothers aged 15–19 years. Basic vaccination coverage increased with higher levels of maternal education, with basic vaccination coverage among children of mothers with no education, primary education, and secondary education or higher at 15% (13–17%), 33% (28–38%), and 47% (45–50%) respectively. Children living in female-headed households had relatively higher basic vaccination coverage of 39% (35–44%) in comparison to 30% (28–32%) in male-headed households. For child characteristics, basic vaccination coverage was similar among female and male children at 31% (29–33%) and 31% (29–34%) respectively, while coverage decreased by birth order with 36% (32–40%) and 23% (20–26%) among first-born and sixth-born respectively. For healthcare characteristics, children of women who had a higher number of antenatal care visits during their pregnancy had higher basic vaccination coverage at 41% (39–44%) for four or more visits and 11% (8.7–13%) for no or unknown number of visits. More than half of all women gave birth at home, and basic vaccination coverage among these children was relatively lower at 20% (18–22%) in comparison to 47% (44–49%) among children born in a public or private clinical facility.

Fig 3. Basic vaccination coverage in Nigeria.

Fig 3

Basic vaccination coverage among children aged 12–23 months in Nigeria by socioeconomic (household wealth, religion, ethnicity), geographic (region, place of residence), maternal (maternal age at birth, maternal education, maternal household head status), child (sex of child, birth order), and healthcare (birth setting, antenatal care) characteristics.

Fig 4. Basic vaccination coverage in Nigeria at the regional level.

Fig 4

Basic vaccination coverage among children aged 12–23 months in Nigeria at the regional level. (The figure is created by the authors using RStudio and naijR package using data from CIA World Factbook. The figure can be reproduced under CC BY 4.0 license).

Fig 5 shows the concentration curve for household wealth-related inequity in basic vaccination coverage, while Table 2 presents the inequities in vaccination card usage rates and vaccination coverage among children aged 12–23 months disaggregated by maternal education, antenatal care, and household wealth in Nigeria, based on Erreygers concentration indices. With respect to maternal education, antenatal care, and household wealth, each of these characteristics had a regressive pro-advantage distribution, with higher vaccination card usage rates and coverage among children from wealthier households, higher maternal education and more antenatal care.

Fig 5. Wealth-related inequity in basic vaccination coverage in Nigeria.

Fig 5

Concentration curve for household wealth-related inequity in basic vaccination coverage among children aged 12–23 months in Nigeria.

Table 2. Inequities in vaccination card usage rates and vaccination coverage in Nigeria.

Maternal education Antenatal care Household wealth
ECI p-value ECI p-value ECI p-value
Vaccination card 0.40 <0.0001 0.36 <0.0001 0.30 <0.0001
Vaccine
BCG 0.48 <0.0001 0.44 <0.0001 0.32 <0.0001
Measles–first dose 0.41 <0.0001 0.36 <0.0001 0.30 <0.0001
DTP-HepB-Hib–third dose 0.48 <0.0001 0.39 <0.0001 0.31 <0.0001
Polio–third dose 0.22 <0.0001 0.22 <0.0001 0.17 <0.0001
Basic vaccination 0.32 <0.0001 0.27 <0.0001 0.24 <0.0001

Inequities in vaccination card usage rates and vaccination coverage among children aged 12–23 months disaggregated by maternal education, antenatal care, and household wealth in Nigeria, based on Erreygers concentration indices (ECI). BCG refers to Bacille Calmette-Guérin vaccine and DTP-HepB-Hib refers to diphtheria, tetanus, pertussis (DTP), hepatitis B (HepB) and Haemophilus Influenzae type b (Hib).

Table 3 and Fig 6 presents the inequities in basic vaccination coverage in Nigeria among children aged 12–23 months associated with socioeconomic (household wealth, religion, ethnicity), geographic (region, place of residence), maternal (maternal age at birth, maternal education, maternal household head status), child (sex of child, birth order), and healthcare (antenatal care, birth setting) characteristics. After controlling for other background characteristics through multiple logistic regression, the adjusted odds ratios (AORs) were significant for the associations between basic vaccination coverage and household wealth, religion, ethnicity, maternal age at birth, maternal education, antenatal care, and birth setting. This model and the AORs include the interaction between household wealth and place of residence (see S3 Table for the strata specific AORs between place of residence and household wealth).

Table 3. Inequities in basic vaccination coverage in Nigeria associated with socioeconomic, geographic, maternal, child, and healthcare characteristics.

Characteristics Population (n = 6059) Mean basic vaccination coverage (% and 95% confidence interval) Crude odds ratio (OR and 95% confidence interval) p-value Adjusted odds ratio (AOR and 95% confidence interval) p-value
Socioeconomic
Household wealth
Poorest 1301 17.2 (14.5, 20.3) 1 <0.0001 1
Poorer 1278 24.6 (21.6, 27.8) 1.57 (1.22, 2.01) 1.38 (0.96, 2.00) 0.086
Middle 1239 29.2 (25.9, 32.7) 1.98 (1.53, 2.56) 1.73 (1.17, 2.53) 0.005
Richer 1156 38.2 (34.1, 42.5) 2.97 (2.27, 3.90) 3.10 (2.03, 4.74) <0.001
Richest 1085 49.1 (45.1, 53.1) 4.64 (3.59, 6.00) 3.21 (2.06, 5.00) <0.001
Religion
Catholic 586 48.8 (43.3, 54.3) 1 <0.0001 1
Other Christian 1883 44.0 (41.0, 47.1) 0.82 (0.65, 1.04) 0.98 (0.76, 1.26) 0.852
Islam 3538 22.6 (20.5, 24.8) 0.31 (0.24, 0.39) 0.96 (0.67, 1.38) 0.823
Traditional 15 22.2 (5.9, 56.3) 0.30 (0.07, 1.36) 0.87 (0.23, 3.25) 0.830
Other 37 14.0 (6.6, 27.3) 0.17 (0.07, 0.40) 0.25 (0.10, 0.60) 0.002
Ethnicity (n = 6057)
Igbo 847 56.3 (51.3, 61.1) 1 <0.0001 1
Ekoi 25 51.5 (31.6, 70.9) 0.82 (0.35, 1.94) 1.96 (0.74, 5.20) 0.178
Fulani 568 12.2 (9.0, 16.2) 0.11 (0.07, 0.16) 0.51 (0.26, 0.97) 0.039
Hausa 1796 19.9 (17.3, 22.8) 0.19 (0.15, 0.25) 0.73 (0.39, 1.36) 0.324
Ibibio 105 42.1 (31.9, 53.1) 0.57 (0.35, 0.90) 1.45 (0.77, 2.75) 0.251
Igala 55 27.6 (14.4, 46.5) 0.30 (0.13, 0.69) 0.61 (0.24, 1.51) 0.283
Ijaw/Izon 171 33.5 (24.7, 43.7) 0.39 (0.24, 0.63) 1.05 (0.54, 2.04) 0.891
Kanuri/Beriberi 148 14.4 (8.8, 22.7) 0.13 (0.07, 0.24) 0.42 (0.15, 1.19) 0.102
Tiv 148 24.6 (16.8, 34.5) 0.25 (0.15, 0.43) 0.56 (0.27, 1.16) 0.117
Yoruba 622 40.8 (35.6, 46.1) 0.53 (0.40, 0.72) 0.70 (0.40, 1.23) 0.215
Other/Don’t know 1574 35.9 (32.4, 39.5) 0.43 (0.34, 0.56) 1.03 (0.63, 1.67) 0.912
Geographic
Region
North Central 1061 30.9 (26.3, 35.8) 1 <0.0001 1
North East 1303 22.9 (19.6, 26.5) 0.66 (0.50, 0.89) 1.06 (0.75, 1.51) 0.724
North West 1697 19.9 (17.1, 23.1) 0.56 (0.42, 0.74) 1.00 (0.67, 1.49) 1.000
South East 698 56.6 (51.0, 62.1) 2.93 (2.13, 4.01) 1.35 (0.78, 2.35) 0.284
South South 637 41.8 (37.2, 46.6) 1.61 (1.20, 2.16) 0.86 (0.57, 1.27) 0.441
South West 663 42.6 (37.3, 48.0) 1.66 (1.22, 2.27) 0.83 (0.56, 1.24) 0.357
Place of residence
Urban 2100 44.2 (41.0, 47.5) 1 <0.0001 1
Rural 3959 22.7 (20.7, 24.8) 0.37 (0.31, 0.44) 0.88 (0.56, 1.37) 0.560
Maternal
Maternal age at birth (years)
15–19 366 15.8 (11.9, 20.9) 1 <0.0001 1
20–34 4330 31.4 (29.3, 33.5) 2.43 (1.72, 3.43) 1.69 (1.15, 2.47) 0.007
35–49 1363 34.5 (30.6, 38.6) 2.80 (1.93, 4.05) 2.25 (1.46, 3.49) <0.001
Maternal education
None 2614 14.8 (12.9, 16.9) 1 <0.0001 1
Primary 881 32.7 (28.1, 37.6) 2.80 (2.15, 3.63) 1.51 (1.14, 1.99) 0.004
Secondary or higher 2564 47.3 (44.5, 50.0) 5.17 (4.27, 6.26) 1.79 (1.39, 2.31) <0.001
Sex of household head
Male 5434 30.3 (28.4, 32.3) 1 <0.0001 1
Female 625 39.1 (34.7, 43.8) 1.48 (1.21, 1.81) 1.09 (0.86, 1.37) 0.474
Child
Sex
Male 3148 31.4 (28.9, 34.0) 1 0.81 1
Female 2911 31.0 (28.7, 33.3) 0.98 (0.85, 1.14) 1.02 (0.88, 1.19) 0.766
Birth order
1st 1157 35.8 (32.1, 39.7) 1 <0.0001 1
2nd– 3rd 2081 33.9 (31.0, 36.9) 0.92 (0.75, 1.13) 0.91 (0.73, 1.14) 0.417
4th– 5th 1412 31.8 (28.6, 35.2) 0.84 (0.66, 1.06) 1.01 (0.79, 1.30) 0.909
6th or higher 1409 22.7 (20.0, 25.6) 0.53 (0.42, 0.65) 0.86 (0.65, 1.14) 0.292
Healthcare
Antenatal care (n = 5824)
None/Don’t know 1529 10.6 (8.7, 12.9) 1 <0.0001 1
1–3 visits 976 24.3 (21.3, 27.6) 2.70 (2.07, 3.53) 2.15 (1.62, 2.85) <0.001
4 or more visits 3319 41.5 (39.2, 43.8) 5.96 (4.71, 7.53) 2.87 (2.21, 3.72) <0.001
Birth setting
Home setting 3415 19.5 (17.5, 21.7) 1 <0.0001 1
Public or private facility 2549 46.7 (44.0, 49.4) 3.61 (3.06, 4.26) 1.32 (1.08, 1.61) 0.006
Other 95 31.2 (19.8, 45.5) 1.87 (0.98, 3.56) 0.77 (0.40, 1.50) 0.444

Bold values represent the statistically significant results.

Fig 6. Inequities in basic vaccination coverage in Nigeria.

Fig 6

Inequities in basic vaccination coverage among children aged 12–23 months in Nigeria associated with socioeconomic (household wealth, religion, ethnicity), geographic (region, place of residence), maternal (maternal age at birth, maternal education, maternal household head status), child (sex of child, birth order), and healthcare (birth setting, antenatal care) characteristics.

Inequities in basic vaccination coverage (1-dose BCG, 3-dose DTP-HepB-Hib, 3-dose polio, and 1-dose measles) in Nigeria among children aged 12–23 months associated with socioeconomic (household wealth, religion, ethnicity), geographic (region, place of residence), maternal (maternal age at birth, maternal education, maternal household head status), child (sex of child, birth order), and healthcare (antenatal care, birth setting) characteristics. Crude and adjusted odds ratios were estimated using simple and multiple logistic regression respectively.

Children living in households of richest wealth quintiles had 221% higher odds (AOR: 3.21 (2.06, 5.00), p < 0.001) of receiving basic vaccinations in comparison to children of the poorest wealth quintiles. However, children living in rural areas in the richer quintile had 64% lower odds (AOR: 0.36 (0.24, 0.53), p < 0.001) and children in rural areas in the richest quintile 50% lower odds (AOR: 0.50 (0.35, 0.72), p <0.001) than children in urban areas. Children whose religion was classified as ‘other’ had 75% lower odds (AOR: 0.25 (0.10, 0.60), p < 0.002) of receiving basic vaccinations than children of Catholic faith. In comparison to children of Igbo ethnicity, children of Fulani ethnicity had 49% lower odds of receiving basic vaccinations (AOR: 0.51 (0.26, 0.97), p = 0.039). Children of mothers aged 35–49 years had 125% higher odds (AOR: 2.25 (1.46, 3.49), p < 0.001) of receiving basic vaccination than children of mothers aged 15–19 years. Children of mothers with secondary or higher education had 79% higher odds (AOR: 1.79 (1.39, 2.31), p < 0.001) of receiving basic vaccination in comparison to children of mothers with no formal education. Children of mothers who had four or more antenatal care visits had 187% higher odds (AOR: 2.87 (2.21, 3.72), p < 0.001) of receiving basic vaccinations than children of mothers who had no antenatal care. Children born in clinical facilities had 32% higher odds (AOR 1.32 (1.08, 1.61), p = 0.006) than children born in home settings of receiving basic vaccinations.

Discussion

We conducted a systematic review to identify the social determinants of childhood immunisation in low- and middle-income countries. We selected household wealth, religion, and ethnicity for socioeconomic characteristics; region and place of residence for geographic characteristics; maternal age at birth, maternal education, and maternal household head status for maternal characteristics; sex of child and birth order for child characteristics; and antenatal care and birth setting for healthcare characteristics. Based on the characteristics identified from the systematic review, we applied a social determinants framework to assess basic vaccination coverage (1-dose BCG, 3-dose DTP-HepB-Hib, 3-dose polio, and 1-dose measles) among children aged 12–23 months in Nigeria using the 2018 Nigeria DHS survey dataset.

The associations identified in this study between basic vaccination coverage and socioeconomic, geographic, maternal, child, and healthcare characteristics identified are supported by other studies. Basic vaccination coverage was associated with household wealth, and families in the richest quintile are more likely to live in urban areas with better access to functional private and public health facilities that provide immunisation services [24, 80]. Mothers in urban areas are more likely to use preventive healthcare services, including childhood immunisation, due to their proximity to healthcare facilities in urban settings and higher educational status in comparison to mothers in rural areas with higher travel costs [8183]. Children in the richer households of rural areas had reduced odds of basic vaccination coverage in comparison to children in the poorest households of urban areas. Children of Fulani ethnicity had lower odds of basic vaccination compared to Igbo children, and there is evidence that awareness of immunisation is low amongst Fulani mothers [84, 85]. Further, Fulani ethnic groups reside in mostly rural settings and are nomadic, limiting their access to health services including immunisation services.

We found that basic vaccination coverage was associated with maternal education. Educated mothers have better awareness and knowledge on childhood immunisation and are more able to overcome cultural barriers to vaccination [86]. Maternal age was associated with basic vaccination coverage and older mothers may have more experience with antenatal clinics and have greater awareness of immunisation services from previous children [26]. They are also more likely to have financial access to immunisation services and live in urban settings with improved access to immunisation services.

Delivery in a health facility and antenatal care were associated with basic vaccination, and to give birth in a health facility indicates that mothers have overcome barriers to accessing health services, and mothers will also receive information on childhood immunisation from healthcare workers there. Hence, utilisation of health services by mothers leads to improved immunisation status of their children [87].

At the regional level, basic vaccination among children ranged from the lowest coverage in the North West region to nearly three times higher coverage in the South East region, although residents in Northern Nigeria are more likely to have immunisation services within 5 km [59]. The large degree of autonomy of different states and the impact of ongoing conflict in parts of the country, in addition to socio-cultural reasons, can explain in part the geographical disparity in immunisation services [14]. However, regional differences in coverage were not significant in the multivariable logistic regression model.

Despite vaccination being provided at no cost to individuals, coverage was still below target levels for even the most advantaged groups and therefore we recommend a proportionate universalism approach with actions proportionate to the level of disadvantage [88, 89]. There is some evidence of payment being required for vaccination, even in public health facilities, and this may threaten vaccination uptake [82]. Both the oversight of immunisation services and public awareness of vaccinations’ no cost status should be strengthened.

Higher coverage with more antenatal care indicates greater engagement with health services and thereby providing more opportunities for vaccine education. The integration of immunisation services to nutrition programmes and paediatric outpatient departments of primary healthcare centres has been shown to improve coverage and decrease drop-out rates in South Sudan [90]. Hence, we recommend efforts to engage with families during health care visits outside of routine immunisation services and to take advantage of these missed opportunities to reach under-immunised children [91].

Our estimates of vaccination coverage in Nigeria for 2018 were lower than national estimates based on administrative reporting from health service providers, though closer to WHO and UNICEF Estimates of National Immunization Coverage (WEUNIC) (see S4 Table) [92]. The coverage gaps have been shown to be systematically underestimated by administrative reporting in Nigeria [93]. In 80% of Nigerian states, the basic vaccination coverage was below the national target of 95% or higher coverage and below the Gavi target of 90% DTP3 coverage [94]. The below target coverage for first doses indicates challenges with access to immunisation services while the decrease in coverage for subsequent doses indicates drop-out due to insufficient knowledge on dose completion [9, 95, 96]. The COVID-19 pandemic has disrupted vaccination globally and coverage was lower than expected in Nigeria in 2020 [17, 18, 97], highlighting the urgent need for catch-up vaccination to close the immunity gaps and prevent vaccine-preventable disease outbreaks [98]. The role of conflict on these disparities is also important to understand. A literature review of conflict and vaccination inferred that conflict-affected countries had vaccination coverage below global levels and conflict affected vaccination services and human resources, including attacks on healthcare workers, which has happened in Nigeria [14, 70]. Our study inferences complement the findings in related studies in Nigeria and other countries.

The proportion of zero-dose children was high and raises the risk of vaccine-preventable disease outbreaks, with nearly 25% of children in rural areas not receiving a single dose of any of the basic vaccinations. Zero-dose children are also likely to lack access to health and welfare services and to suffer from multiple sources of deprivation [99, 100]. More than 50% of children do not have vaccination cards and nearly 60% of children do not have birth registrations [101] - improving uptake of vaccination cards and birth registrations would help in part to address the barriers for vaccine access for all children, including zero-dose children.

Our study has limitations, and we cannot estimate causal-effect relationships nor temporal inferences due to the cross-sectional study design of 2018 Nigeria DHS. Our study has similar biases that are associated with DHS surveys, including recall bias, measurement bias, and social desirability bias which tend to overestimate vaccination coverage. In particular, only 49% of children had a vaccination card and when a vaccination card was not available for a child, their mother was asked to recall their vaccinations, which may lead to an overestimation of coverage.

For future work, we recommend qualitative research to understand the barriers and enablers of childhood vaccination and their associations with socioeconomic, geographic, maternal, child, and healthcare characteristics which would be valuable to adapt vaccination programmes to improve coverage equitably in Nigeria.

Conclusions

We identified the inequities in basic vaccination coverage by socioeconomic, geographic, maternal, child, and healthcare characteristics among children aged 12–23 months in Nigeria using a social determinants of health perspective. In conclusion, we infer that inequities in basic vaccination were associated with lower coverage among children living in poorer households, belonging to Fulani ethnicity, born in home settings in Nigeria, with younger mothers at birth, with mothers with no formal education and with mothers who had no antenatal care visits. We recommend a proportionate universalism approach with targeted vaccination programmes proportionate to the level of disadvantage for addressing the immunisation barriers faced by these underserved subpopulations. This will improve coverage and reduce inequities in childhood immunisation associated with socioeconomic, geographic, maternal, child, and healthcare characteristics in Nigeria.

Supporting information

S1 Checklist. PRISMA checklist.

(DOCX)

pone.0297326.s001.docx (32.8KB, docx)
S1 Table. Routine vaccination schedule of under 1-year-old children in Nigeria.

(DOCX)

pone.0297326.s002.docx (13KB, docx)
S2 Table. Vaccination coverage and vaccination card usage rates in Nigeria.

(DOCX)

pone.0297326.s003.docx (15.2KB, docx)
S3 Table. Interaction effects.

(DOCX)

pone.0297326.s004.docx (24.1KB, docx)
S4 Table. Vaccine coverage.

Vaccine coverage estimates for Nigeria in 2018 based on DHS, WUENIC (WHO-UNICEF), administrative, and official country sources.

(DOCX)

pone.0297326.s005.docx (13.2KB, docx)
S1 Fig. PRISMA flowchart.

The Preferred Reporting Items for Systematic Reviews and Meta Analyses (PRISMA) flow diagram of articles’ identification, screening, eligibility, and inclusion in the systematic review is illustrated.

(DOCX)

pone.0297326.s006.docx (27.1KB, docx)

Acknowledgments

We thank the DHS Program for access to the 2018 Nigeria Demographic and Health Survey dataset.

Abbreviations

AOR

Adjusted odds ratio

BCG

Bacille Calmette-Guérin vaccine

DHS

Demographic Health Survey

DTP

Diphtheria, tetanus and pertussis containing vaccine

DTP-HepB-Hib

Diphtheria, tetanus, pertussis, hepatitis B and Haemophilus influenzae type B

ECI

Erreygers concentration indices

EPI

Expanded Programme of Immunization

Gavi

Global Alliance for Vaccines and Immunisations

LGA

Local Government Area

LMIC

Low- and Middle-Income Countries

PRISMA

Preferred Reporting Items for Systematic Reviews and Meta-Analyses

SDG

Sustainable Development Goals

UNICEF

United Nations Children’s Fund

WHO

World Health Organisation

WUENIC

WHO and UNICEF estimates of national immunization coverage

Data Availability

The 2018 Nigeria DHS data set is publicly available and accessible upon registration for legitimate research purposes on the DHS website at https://dhsprogram.com/methodology/survey/survey-display-528.cfm. To download DHS datasets, researchers must register as a DHS data user at https://dhsprogram.com/data/new-user-registration.cfm.

Funding Statement

KA is supported by Save the Children, Vaccine Impact Modelling Consortium (INV-034281), and the Japan Agency for Medical Research and Development (JP223fa627004). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.

References

  • 1.UNDP. World Population Prospects—Population Division—United Nations. 2019 [cited 1 Nov 2019]. Available: https://population.un.org/wpp/
  • 2.World Bank. Nigeria Overview: Development news, research, data | World Bank. 2020 [cited 21 Sep 2021]. Available: https://www.worldbank.org/en/country/nigeria/overview
  • 3.Piot P, Larson HJ, O’Brien KL, N’kengasong J, Ng E, Sow S, et al. Immunization: vital progress, unfinished agenda. Nature. 2019;575: 119–129. doi: 10.1038/s41586-019-1656-7 [DOI] [PubMed] [Google Scholar]
  • 4.Rodrigues CMC, Plotkin SA. Impact of vaccines; health, economic and social perspectives. Front Microbiol. 2020;11: 1526. doi: 10.3389/fmicb.2020.01526 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 5.UNICEF. IGME: Levels and Trends in Child Mortality—UNICEF DATA. 2020 [cited 21 Sep 2021]. Available: https://data.unicef.org/resources/levels-and-trends-in-child-mortality/
  • 6.WHO. Immunization. 2019 [cited 21 Sep 2021]. Available: https://www.who.int/news-room/facts-in-pictures/detail/immunization
  • 7.Carter A, Msemburi W, Sim SY, A.M. Gaythorpe K, Lindstrand A, Hutubessy RCW. Modeling the Impact of Vaccination for the Immunization Agenda 2030: Deaths Averted Due to Vaccination Against 14 Pathogens in 194 Countries from 2021–2030. SSRN Journal. 2021. doi: 10.2139/ssrn.3830781 [DOI] [PubMed] [Google Scholar]
  • 8.Gavi. Facts and figures. 2021 [cited 21 Sep 2021]. Available: https://www.gavi.org/programmes-impact/our-impact/facts-and-figures
  • 9.Cata-Preta BO, Santos TM, Mengistu T, Hogan DR, Barros AJD, Victora CG. Zero-dose children and the immunisation cascade: Understanding immunisation pathways in low and middle-income countries. Vaccine. 2021;39: 4564–4570. doi: 10.1016/j.vaccine.2021.02.072 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 10.Decouttere C, De Boeck K, Vandaele N. Advancing sustainable development goals through immunization: a literature review. Global Health. 2021;17: 95. doi: 10.1186/s12992-021-00745-w [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 11.WHO. Immunization Agenda 2030: A Global Strategy to Leave No One Behind. 2020 [cited 11 Jan 2021]. Available: https://www.who.int/teams/immunization-vaccines-and-biologicals/strategies/ia2030 [DOI] [PubMed]
  • 12.Keja K, Chan C, Hayden G, Henderson RH. Expanded programme on immunization. World Health Stat Q. 1988;41: 59–63. [PubMed] [Google Scholar]
  • 13.Sorungbe AO. Expanded programme on immunization in Nigeria. Rev Infect Dis. 1989;11 Suppl 3: S509–11. doi: 10.1093/clinids/11.supplement_3.s509 [DOI] [PubMed] [Google Scholar]
  • 14.National Primary Health Care Development Agency. Comprehensive EPI Multi-Year Plan 2016–2020. Federal Ministry of Health, Nigeria; 2015.
  • 15.Gavi. Successfully transitioning Nigeria from Gavi support. 2018 [cited 21 Sep 2021]. Available: https://www.gavi.org/sites/default/files/board_meetings/2018/6_Jun/05%20-%20Successfully%20transitioning%20Nigeria%20from%20Gavi%20support.pdf
  • 16.WHO Africa. NERICC-Nigeria’s panacea to routine immunization and primary health care strengthening. | WHO | Regional Office for Africa. 2019 [cited 21 Sep 2021]. Available: https://www.afro.who.int/news/nericc-nigerias-panacea-routine-immunization-and-primary-health-care-strengthening
  • 17.Causey K, Fullman N, Sorensen RJD, Galles NC, Zheng P, Aravkin A, et al. Estimating global and regional disruptions to routine childhood vaccine coverage during the COVID-19 pandemic in 2020: a modelling study. Lancet. 2021;398: 522–534. doi: 10.1016/S0140-6736(21)01337-4 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 18.Fahriani M, Anwar S, Yufika A, Bakhtiar B, Wardani E, Winardi W, et al. Disruption of childhood vaccination during the COVID-19 pandemic in Indonesia. Narra J. 2021;1. doi: 10.52225/narraj.v1i1.7 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 19.Oku A, Oyo-Ita A, Glenton C, Fretheim A, Eteng G, Ames H, et al. Factors affecting the implementation of childhood vaccination communication strategies in Nigeria: a qualitative study. BMC Public Health. 2017;17: 200. doi: 10.1186/s12889-017-4020-6 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 20.Marmot M, Friel S, Bell R, Houweling TAJ, Taylor S, Commission on Social Determinants of Health. Closing the gap in a generation: health equity through action on the social determinants of health. Lancet. 2008;372: 1661–1669. doi: 10.1016/S0140-6736(08)61690-6 [DOI] [PubMed] [Google Scholar]
  • 21.WHO. Social determinants of health. 2021 [cited 18 Oct 2022]. Available: https://www.who.int/health-topics/social-determinants-of-health#tab=tab_3
  • 22.Mulholland E, Smith L, Carneiro I, Becher H, Lehmann D. Equity and child-survival strategies. Bull World Health Organ. 2008;86: 399–407. doi: 10.2471/blt.07.044545 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 23.Arcaya MC, Arcaya AL, Subramanian SV. Inequalities in health: definitions, concepts, and theories. Glob Health Action. 2015;8: 27106. doi: 10.3402/gha.v8.27106 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 24.NPC/Nigeria, ICF. Nigeria Demographic and Health Survey 2018. National Population Commission Nigeria and ICF; 2019. [Google Scholar]
  • 25.Croft TN, Marshall AMJ, Allen CK. Guide to DHS Statistics. Rockville, Maryland, USA: ICF; 2018. [Google Scholar]
  • 26.WHO. WHO | Explorations of inequality: Childhood immunization. 2018 [cited 18 Sep 2019]. Available: https://apps.who.int/iris/handle/10665/272864
  • 27.Moher D, Liberati A, Tetzlaff J, Altman DG, PRISMA Group. Preferred reporting items for systematic reviews and meta-analyses: The PRISMA statement. PLoS Med. 2009;6: e1000097. doi: 10.1371/journal.pmed.1000097 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 28.StataCorp. Stata: software for statistics and data science. College Station, Texas: StataCorp LP; 2019. [Google Scholar]
  • 29.Kirkwood BR, Sterne JAC. Essential Medical Statistics. 2nd ed. Wiley; 2003. [Google Scholar]
  • 30.WHO. Health Inequality Monitoring with a special focus on low- and middle-income countries. World Health Organization; 2013. Available: https://apps.who.int/iris/handle/10665/85345 [Google Scholar]
  • 31.R Core Team. R: A language and environment for statistical computing. Vienna, Austria: R Foundation for Statistical Computing; 2019. [Google Scholar]
  • 32.Shenton LM, Wagner AL, Carlson BF, Mubarak MY, Boulton ML. Vaccination status of children aged 1–4 years in Afghanistan and associated factors, 2015. Vaccine. 2018;36: 5141–5149. doi: 10.1016/j.vaccine.2018.07.020 [DOI] [PubMed] [Google Scholar]
  • 33.Oliveira MFS de, Martinez EZ, Rocha JSY. Factors associated with vaccination coverage in children < 5 years in Angola. Rev Saude Publica. 2014;48: 906–915. doi: 10.1590/S0034-8910.2014048005284 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 34.Rahman A, Reza AAS, Bhuiyan BA, Alam N, Dasgupta SK, Mostari S, et al. Equity and determinants of routine child immunisation programme among tribal and non-tribal populations in rural Tangail subdistrict, Bangladesh: a cohort study. BMJ Open. 2018;8: e022634. doi: 10.1136/bmjopen-2018-022634 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 35.Vyas P, Kim D, Adams A. Understanding spatial and contextual factors influencing intraregional differences in child vaccination coverage in Bangladesh. Asia Pac J Public Health. 2019;31: 51–60. doi: 10.1177/1010539518813604 [DOI] [PubMed] [Google Scholar]
  • 36.Nda’chi Deffo R, Fomba Kamga B. Do the dynamics of vaccine programs improve the full immunization of children under the age of five in Cameroon? BMC Health Serv Res. 2020;20: 953. doi: 10.1186/s12913-020-05745-x [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 37.Ashbaugh HR, Hoff NA, Doshi RH, Alfonso VH, Gadoth A, Mukadi P, et al. Predictors of measles vaccination coverage among children 6–59 months of age in the Democratic Republic of the Congo. Vaccine. 2018;36: 587–593. doi: 10.1016/j.vaccine.2017.11.049 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 38.Lakew Y, Bekele A, Biadgilign S. Factors influencing full immunization coverage among 12–23 months of age children in Ethiopia: evidence from the national demographic and health survey in 2011. BMC Public Health. 2015;15: 728. doi: 10.1186/s12889-015-2078-6 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 39.Geweniger A, Abbas KM. Childhood vaccination coverage and equity impact in Ethiopia by socioeconomic, geographic, maternal, and child characteristics. Vaccine. 2020;38: 3627–3638. doi: 10.1016/j.vaccine.2020.03.040 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 40.Gram L, Soremekun S, ten Asbroek A, Manu A, O’Leary M, Hill Z, et al. Socio-economic determinants and inequities in coverage and timeliness of early childhood immunisation in rural Ghana. Trop Med Int Health. 2014;19: 802–811. doi: 10.1111/tmi.12324 [DOI] [PubMed] [Google Scholar]
  • 41.Shrivastwa N, Gillespie BW, Kolenic GE, Lepkowski JM, Boulton ML. Predictors of vaccination in India for children aged 12–36 months. Vaccine. 2015;33 Suppl 4: D99–105. doi: 10.1016/j.vaccine.2015.09.034 [DOI] [PubMed] [Google Scholar]
  • 42.Devasenapathy N, Ghosh Jerath S, Sharma S, Allen E, Shankar AH, Zodpey S. Determinants of childhood immunisation coverage in urban poor settlements of Delhi, India: a cross-sectional study. BMJ Open. 2016;6: e013015. doi: 10.1136/bmjopen-2016-013015 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 43.Khan J, Shil A, Prakash R. Exploring the spatial heterogeneity in different doses of vaccination coverage in India. PLoS ONE. 2018;13: e0207209. doi: 10.1371/journal.pone.0207209 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 44.Francis MR, Nohynek H, Larson H, Balraj V, Mohan VR, Kang G, et al. Factors associated with routine childhood vaccine uptake and reasons for non-vaccination in India: 1998–2008. Vaccine. 2018;36: 6559–6566. doi: 10.1016/j.vaccine.2017.08.026 [DOI] [PubMed] [Google Scholar]
  • 45.Kannankeril Joseph VJ. Understanding inequalities in child immunization in India: a decomposition approach. J Biosoc Sci. 2021; 1–13. doi: 10.1017/S0021932021000110 [DOI] [PubMed] [Google Scholar]
  • 46.Srivastava S, Kumar P, Chauhan S, Banerjee A. Household expenditure for immunization among children in India: a two-part model approach. BMC Health Serv Res. 2021;21: 1001. doi: 10.1186/s12913-021-07011-0 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 47.Siramaneerat I, Agushybana F. Inequalities in immunization coverage in Indonesia: a multilevel analysis. Rural Remote Health. 2021;21: 6348. doi: 10.22605/RRH6348 [DOI] [PubMed] [Google Scholar]
  • 48.Van Malderen C, Ogali I, Khasakhala A, Muchiri SN, Sparks C, Van Oyen H, et al. Decomposing Kenyan socio-economic inequalities in skilled birth attendance and measles immunization. Int J Equity Health. 2013;12: 3. doi: 10.1186/1475-9276-12-3 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 49.Masters NB, Wagner AL, Carlson BF, Muuo SW, Mutua MK, Boulton ML. Childhood vaccination in Kenya: socioeconomic determinants and disparities among the Somali ethnic community. Int J Public Health. 2019;64: 313–322. doi: 10.1007/s00038-018-1187-2 [DOI] [PubMed] [Google Scholar]
  • 50.Allan S, Adetifa IMO, Abbas K. Inequities in childhood immunisation coverage associated with socioeconomic, geographic, maternal, child, and place of birth characteristics in Kenya. BMC Infect Dis. 2021;21: 553. doi: 10.1186/s12879-021-06271-9 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 51.Mutua MK, Mohamed SF, Iddi S, Muyingo S, Mwangi B, Kadengye D, et al. Do inequalities exist in the disadvantaged populations? Levels and trends of full and on-time vaccination coverage in two Nairobi urban informal settlements. Global Epidemiology. 2020;2: 100044. doi: 10.1016/j.gloepi.2020.100044 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 52.Sychareun V, Rowlands L, Vilay P, Durham J, Morgan A. The determinants of vaccination in a semi-rural area of Vientiane City, Lao People’s Democratic Republic: a qualitative study. Health Res Policy Syst. 2019;17: 2. doi: 10.1186/s12961-018-0407-9 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 53.Abebe DS, Nielsen VO, Finnvold JE. Regional inequality and vaccine uptake: a multilevel analysis of the 2007 Welfare Monitoring Survey in Malawi. BMC Public Health. 2012;12: 1075. doi: 10.1186/1471-2458-12-1075 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 54.Ntenda PAM, Chuang K-Y, Tiruneh FN, Chuang Y-C. Analysis of the effects of individual and community level factors on childhood immunization in Malawi. Vaccine. 2017;35: 1907–1917. doi: 10.1016/j.vaccine.2017.02.036 [DOI] [PubMed] [Google Scholar]
  • 55.Daca C, Sebastian MS, Arnaldo C, Schumann B. Socio-economic and demographic factors associated with reproductive and child health preventive care in Mozambique: a cross-sectional study. Int J Equity Health. 2020;19: 200. doi: 10.1186/s12939-020-01303-3 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 56.Patel PN, Hada M, Carlson BF, Boulton ML. Immunization status of children in Nepal and associated factors, 2016. Vaccine. 2021;39: 5831–5838. doi: 10.1016/j.vaccine.2021.08.059 [DOI] [PubMed] [Google Scholar]
  • 57.Antai D. Inequitable childhood immunization uptake in Nigeria: a multilevel analysis of individual and contextual determinants. BMC Infect Dis. 2009;9: 181. doi: 10.1186/1471-2334-9-181 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 58.Antai D. Gender inequities, relationship power, and childhood immunization uptake in Nigeria: a population-based cross-sectional study. Int J Infect Dis. 2012;16: e136–45. doi: 10.1016/j.ijid.2011.11.004 [DOI] [PubMed] [Google Scholar]
  • 59.Eboreime E, Abimbola S, Bozzani F. Access to Routine Immunization: A Comparative Analysis of Supply-Side Disparities between Northern and Southern Nigeria. PLoS ONE. 2015;10: e0144876. doi: 10.1371/journal.pone.0144876 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 60.Ataguba JE, Ojo KO, Ichoku HE. Explaining socio-economic inequalities in immunization coverage in Nigeria. Health Policy Plan. 2016;31: 1212–1224. doi: 10.1093/heapol/czw053 [DOI] [PubMed] [Google Scholar]
  • 61.Uzochukwu BS, Okeke CC, Envuladu E, Mbachu C, Okwuosa C, Onwujekwe OE. Inequity in access to childhood immunization in Enugu urban, Southeast Nigeria. Niger J Clin Pract. 2017;20: 971–977. doi: 10.4103/njcp.njcp_375_16 [DOI] [PubMed] [Google Scholar]
  • 62.Uthman OA, Adedokun ST, Olukade T, Watson S, Adetokunboh O, Adeniran A, et al. Children who have received no routine polio vaccines in Nigeria: Who are they and where do they live? Hum Vaccin Immunother. 2017;13: 2111–2122. doi: 10.1080/21645515.2017.1336590 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 63.Obanewa OA, Newell ML. The role of place of residency in childhood immunisation coverage in Nigeria: analysis of data from three DHS rounds 2003–2013. BMC Public Health. 2020;20: 123. doi: 10.1186/s12889-020-8170-6 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 64.Siddiqui NT, Owais A, Agha A, Karim MS, Zaidi AKM. Ethnic disparities in routine immunization coverage: a reason for persistent poliovirus circulation in Karachi, Pakistan? Asia Pac J Public Health. 2014;26: 67–76. doi: 10.1177/1010539513475648 [DOI] [PubMed] [Google Scholar]
  • 65.Canavan ME, Sipsma HL, Kassie GM, Bradley EH. Correlates of complete childhood vaccination in East African countries. PLoS ONE. 2014;9: e95709. doi: 10.1371/journal.pone.0095709 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 66.Wariri O, Edem B, Nkereuwem E, Nkereuwem OO, Umeh G, Clark E, et al. Tracking coverage, dropout and multidimensional equity gaps in immunisation systems in West Africa, 2000–2017. BMJ Glob Health. 2019;4: e001713. doi: 10.1136/bmjgh-2019-001713 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 67.Ndwandwe D, Uthman OA, Adamu AA, Sambala EZ, Wiyeh AB, Olukade T, et al. Decomposing the gap in missed opportunities for vaccination between poor and non-poor in sub-Saharan Africa: A Multicountry Analyses. Hum Vaccin Immunother. 2018;14: 2358–2364. doi: 10.1080/21645515.2018.1467685 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 68.Sambala EZ, Uthman OA, Adamu AA, Ndwandwe D, Wiyeh AB, Olukade T, et al. Mind the Gap: What explains the education-related inequality in missed opportunities for vaccination in sub-Saharan Africa? Compositional and structural characteristics. Hum Vaccin Immunother. 2018;14: 2365–2372. doi: 10.1080/21645515.2018.1460985 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 69.Ameyaw EK, Kareem YO, Ahinkorah BO, Seidu A-A, Yaya S. Decomposing the rural-urban gap in factors associated with childhood immunisation in sub-Saharan Africa: evidence from surveys in 23 countries. BMJ Glob Health. 2021;6. doi: 10.1136/bmjgh-2020-003773 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 70.Grundy J, Biggs B-A. The impact of conflict on immunisation coverage in 16 countries. Int J Health Policy Manag. 2019;8: 211–221. doi: 10.15171/ijhpm.2018.127 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 71.Arsenault C, Harper S, Nandi A, Rodríguez JMM, Hansen PM, Johri M. An equity dashboard to monitor vaccination coverage. Bull World Health Organ. 2017;95: 128–134. doi: 10.2471/BLT.16.178079 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 72.Arsenault C, Johri M, Nandi A, Mendoza Rodríguez JM, Hansen PM, Harper S. Country-level predictors of vaccination coverage and inequalities in Gavi-supported countries. Vaccine. 2017;35: 2479–2488. doi: 10.1016/j.vaccine.2017.03.029 [DOI] [PubMed] [Google Scholar]
  • 73.Bosch-Capblanch X, Banerjee K, Burton A. Unvaccinated children in years of increasing coverage: how many and who are they? Evidence from 96 low- and middle-income countries. Trop Med Int Health. 2012;17: 697–710. doi: 10.1111/j.1365-3156.2012.02989.x [DOI] [PubMed] [Google Scholar]
  • 74.Merten S, Martin Hilber A, Biaggi C, Secula F, Bosch-Capblanch X, Namgyal P, et al. Gender Determinants of Vaccination Status in Children: Evidence from a Meta-Ethnographic Systematic Review. PLoS ONE. 2015;10: e0135222. doi: 10.1371/journal.pone.0135222 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 75.Hinman AR, McKinlay MA. Immunization Equity. Am J Prev Med. 2015;49: S399–405. doi: 10.1016/j.amepre.2015.04.018 [DOI] [PubMed] [Google Scholar]
  • 76.Awoh AB, Plugge E. Immunisation coverage in rural-urban migrant children in low and middle-income countries (LMICs): a systematic review and meta-analysis. J Epidemiol Community Health. 2016;70: 305–311. doi: 10.1136/jech-2015-205652 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 77.Hosseinpoor AR, Bergen N, Schlotheuber A, Gacic-Dobo M, Hansen PM, Senouci K, et al. State of inequality in diphtheria-tetanus-pertussis immunisation coverage in low-income and middle-income countries: a multicountry study of household health surveys. Lancet Glob Health. 2016;4: e617–26. doi: 10.1016/S2214-109X(16)30141-3 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 78.Hajizadeh M. Socioeconomic inequalities in child vaccination in low/middle-income countries: what accounts for the differences? J Epidemiol Community Health. 2018;72: 719–725. doi: 10.1136/jech-2017-210296 [DOI] [PubMed] [Google Scholar]
  • 79.Hajizadeh M. Decomposing socioeconomic inequality in child vaccination in the Gambia, the Kyrgyz Republic and Namibia. Vaccine. 2019;37: 6609–6616. doi: 10.1016/j.vaccine.2019.09.054 [DOI] [PubMed] [Google Scholar]
  • 80.Adebowale A, Obembe T, Bamgboye E. Relationship between household wealth and childhood immunization in core-North Nigeria. Afr Health Sci. 2019;19: 1582–1593. doi: 10.4314/ahs.v19i1.33 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 81.Adenike O-B, Adejumoke J, Olufunmi O, Ridwan O. Maternal characteristics and immunization status of children in North Central of Nigeria. Pan Afr Med J. 2017;26: 159. doi: 10.11604/pamj.2017.26.159.11530 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 82.Sibeudu FT, Uzochukwu BS, Onwujekwe OE. Rural-urban comparison of routine immunization utilization and its determinants in communities in Anambra States, Nigeria. SAGE Open Med. 2019;7: 2050312118823893. doi: 10.1177/2050312118823893 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 83.Okafor IP, Dolapo DC, Onigbogi MO, Iloabuchi IG. Rural-urban disparities in maternal immunization knowledge and childhood health-seeking behavior in Nigeria: a mixed method study. Afr Health Sci. 2014;14: 339–347. doi: 10.4314/ahs.v14i2.8 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 84.Dao MY, Brieger WR. Immunization for the migrant fulani: identifying an under-served population in southwestern Nigeria. Int Q Community Health Educ. 1994;15: 21–32. doi: 10.2190/VKHL-JXC5-WK91-8QGQ [DOI] [PubMed] [Google Scholar]
  • 85.Afolabi RF, Salawu MM, Gbadebo BM, Salawu AT, Fagbamigbe AF, Adebowale AS. Ethnicity as a cultural factor influencing complete vaccination among children aged 12–23 months in Nigeria. Hum Vaccin Immunother. 2021;17: 2008–2017. doi: 10.1080/21645515.2020.1870394 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 86.Balogun SA, Yusuff HA, Yusuf KQ, Al-Shenqiti AM, Balogun MT, Tettey P. Maternal education and child immunization: the mediating roles of maternal literacy and socioeconomic status. Pan Afr Med J. 2017;26: 217. doi: 10.11604/pamj.2017.26.217.11856 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 87.Adedokun ST, Uthman OA, Adekanmbi VT, Wiysonge CS. Incomplete childhood immunization in Nigeria: a multilevel analysis of individual and contextual factors. BMC Public Health. 2017;17: 236. doi: 10.1186/s12889-017-4137-7 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 88.Carey G, Crammond B, De Leeuw E. Towards health equity: a framework for the application of proportionate universalism. Int J Equity Health. 2015;14: 81. doi: 10.1186/s12939-015-0207-6 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 89.Marmot M, Bell R. Fair society, healthy lives. Public Health. 2012;126 Suppl 1: S4–10. doi: 10.1016/j.puhe.2012.05.014 [DOI] [PubMed] [Google Scholar]
  • 90.Idris IO, Obwoya JG, Tapkigen J, Lamidi SA, Ochagu VA, Abbas K. Impact evaluation of immunisation service integration to nutrition programmes and paediatric outpatient departments of primary healthcare centres in Rumbek East and Rumbek Centre counties of South Sudan. Family Med Commun Hlth. 2021;9. doi: 10.1136/fmch-2021-001034 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 91.Restrepo-Méndez MC, Barros AJD, Wong KLM, Johnson HL, Pariyo G, Wehrmeister FC, et al. Missed opportunities in full immunization coverage: findings from low- and lower-middle-income countries. Glob Health Action. 2016;9: 30963. doi: 10.3402/gha.v9.30963 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 92.WHO, UNICEF. WUENIC (WHO/UNICEF Estimates of National Immunization Coverage) estimates—Vaccines monitoring system 2019 Global Summary Reference Time Series. 2019 [cited 11 Jun 2023]. Available: https://www.who.int/teams/immunization-vaccines-and-biologicals/immunization-analysis-and-insights/global-monitoring/immunization-coverage/who-unicef-estimates-of-national-immunization-coverage
  • 93.Gunnala R, Ogbuanu IU, Adegoke OJ, Scobie HM, Uba BV, Wannemuehler KA, et al. Routine Vaccination Coverage in Northern Nigeria: Results from 40 District-Level Cluster Surveys, 2014–2015. PLoS ONE. 2016;11: e0167835. doi: 10.1371/journal.pone.0167835 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 94.Gavi. 2019 Annual Progress Report. 2020 [cited 21 Sep 2021]. Available: https://www.gavi.org/sites/default/files/programmes-impact/our-impact/apr/Gavi-Progress-Report-2019_1.pdf
  • 95.Adedire EB, Ajayi I, Fawole OI, Ajumobi O, Kasasa S, Wasswa P, et al. Immunisation coverage and its determinants among children aged 12–23 months in Atakumosa-west district, Osun State Nigeria: a cross-sectional study. BMC Public Health. 2016;16: 905. doi: 10.1186/s12889-016-3531-x [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 96.Odusanya OO, Alufohai EF, Meurice FP, Ahonkhai VI. Determinants of vaccination coverage in rural Nigeria. BMC Public Health. 2008;8: 381. doi: 10.1186/1471-2458-8-381 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 97.Tatar M, Shoorekchali JM, Faraji MR, Wilson FA. International COVID-19 vaccine inequality amid the pandemic: Perpetuating a global crisis? J Glob Health. 2021;11: 03086. doi: 10.7189/jogh.11.03086 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 98.WHO. Leave No One Behind: Guidance for Planning and Implementing Catch-up Vaccination. 2020 [cited 1 Feb 2021]. Available: https://www.who.int/teams/immunization-vaccines-and-biologicals/essential-programme-on-immunization/implementation/catch-up-vaccination/
  • 99.WHO. Progress and Challenges with Achieving Universal Immunization Coverage. 2020 [cited 22 Dec 2022]. Available: https://www.who.int/publications/m/item/progress-and-challenges-with-achievinguniversal-immunization-coverage
  • 100.Bhatia A, Krieger N, Beckfield J, Barros AJD, Victora C. Are inequities decreasing? Birth registration for children under five in low-income and middle-income countries, 1999–2016. BMJ Glob Health. 2019;4: e001926. doi: 10.1136/bmjgh-2019-001926 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 101.United Nations Children’s Fund,. Birth Registration for Every Child by 2030: Are we on track? UNICEF; 2019. [Google Scholar]

Decision Letter 0

Harapan Harapan

13 Mar 2023

PONE-D-23-02804Childhood vaccination coverage by socioeconomic, geographic, maternal, child, and healthcare characteristics in Nigeria: equity impact analysisPLOS ONE

Dear Dr. Williams,

Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process.

Please submit your revised manuscript by Apr 27 2023 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file.

Please include the following items when submitting your revised manuscript:

  • A rebuttal letter that responds to each point raised by the academic editor and reviewer(s). You should upload this letter as a separate file labeled 'Response to Reviewers'.

  • A marked-up copy of your manuscript that highlights changes made to the original version. You should upload this as a separate file labeled 'Revised Manuscript with Track Changes'.

  • An unmarked version of your revised paper without tracked changes. You should upload this as a separate file labeled 'Manuscript'.

If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter.

If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: https://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols. Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols.

We look forward to receiving your revised manuscript.

Kind regards,

Harapan Harapan, MD, PhD

Academic Editor

PLOS ONE

Journal Requirements:

When submitting your revision, we need you to address these additional requirements.

1. Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming. The PLOS ONE style templates can be found at 

https://journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf and 

https://journals.plos.org/plosone/s/file?id=ba62/PLOSOne_formatting_sample_title_authors_affiliations.pdf

2. Thank you for stating in your Funding Statement: 

"KA is supported by the Vaccine Impact Modelling Consortium (OPP1157270). 

" ext-link-type="uri" xlink:type="simple">https://www.vaccineimpact.org/"

Please provide an amended statement that declares *all* the funding or sources of support (whether external or internal to your organization) received during this study, as detailed online in our guide for authors at http://journals.plos.org/plosone/s/submit-now.  Please also include the statement “There was no additional external funding received for this study.” in your updated Funding Statement. 

Please include your amended Funding Statement within your cover letter. We will change the online submission form on your behalf.

3. Your ethics statement should only appear in the Methods section of your manuscript. If your ethics statement is written in any section besides the Methods, please move it to the Methods section and delete it from any other section. Please ensure that your ethics statement is included in your manuscript, as the ethics statement entered into the online submission form will not be published alongside your manuscript. 

4. We note that Figure 4 in your submission contain map image which may be copyrighted. All PLOS content is published under the Creative Commons Attribution License (CC BY 4.0), which means that the manuscript, images, and Supporting Information files will be freely available online, and any third party is permitted to access, download, copy, distribute, and use these materials in any way, even commercially, with proper attribution. For these reasons, we cannot publish previously copyrighted maps or satellite images created using proprietary data, such as Google software (Google Maps, Street View, and Earth). For more information, see our copyright guidelines: http://journals.plos.org/plosone/s/licenses-and-copyright.

We require you to either (1) present written permission from the copyright holder to publish these figures specifically under the CC BY 4.0 license, or (2) remove the figures from your submission:

a. You may seek permission from the original copyright holder of Figure 4 to publish the content specifically under the CC BY 4.0 license.  

We recommend that you contact the original copyright holder with the Content Permission Form (http://journals.plos.org/plosone/s/file?id=7c09/content-permission-form.pdf) and the following text:

“I request permission for the open-access journal PLOS ONE to publish XXX under the Creative Commons Attribution License (CCAL) CC BY 4.0 (http://creativecommons.org/licenses/by/4.0/). Please be aware that this license allows unrestricted use and distribution, even commercially, by third parties. Please reply and provide explicit written permission to publish XXX under a CC BY license and complete the attached form.”

Please upload the completed Content Permission Form or other proof of granted permissions as an ""Other"" file with your submission.

In the figure caption of the copyrighted figure, please include the following text: “Reprinted from [ref] under a CC BY license, with permission from [name of publisher], original copyright [original copyright year].”

b. If you are unable to obtain permission from the original copyright holder to publish these figures under the CC BY 4.0 license or if the copyright holder’s requirements are incompatible with the CC BY 4.0 license, please either i) remove the figure or ii) supply a replacement figure that complies with the CC BY 4.0 license. Please check copyright information on all replacement figures and update the figure caption with source information. If applicable, please specify in the figure caption text when a figure is similar but not identical to the original image and is therefore for illustrative purposes only.

The following resources for replacing copyrighted map figures may be helpful:

USGS National Map Viewer (public domain): http://viewer.nationalmap.gov/viewer/

The Gateway to Astronaut Photography of Earth (public domain): http://eol.jsc.nasa.gov/sseop/clickmap/

Maps at the CIA (public domain): https://www.cia.gov/library/publications/the-world-factbook/index.html and https://www.cia.gov/library/publications/cia-maps-publications/index.html

NASA Earth Observatory (public domain): http://earthobservatory.nasa.gov/

Landsat: http://landsat.visibleearth.nasa.gov/

USGS EROS (Earth Resources Observatory and Science (EROS) Center) (public domain): http://eros.usgs.gov/#

Natural Earth (public domain): http://www.naturalearthdata.com/

5. Please include captions for your Supporting Information files at the end of your manuscript, and update any in-text citations to match accordingly. Please see our Supporting Information guidelines for more information: http://journals.plos.org/plosone/s/supporting-information. 

[Note: HTML markup is below. Please do not edit.]

Reviewers' comments:

Reviewer's Responses to Questions

Comments to the Author

1. Is the manuscript technically sound, and do the data support the conclusions?

The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented.

Reviewer #1: Partly

Reviewer #2: Yes

**********

2. Has the statistical analysis been performed appropriately and rigorously?

Reviewer #1: No

Reviewer #2: Yes

**********

3. Have the authors made all data underlying the findings in their manuscript fully available?

The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified.

Reviewer #1: Yes

Reviewer #2: Yes

**********

4. Is the manuscript presented in an intelligible fashion and written in standard English?

PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here.

Reviewer #1: Yes

Reviewer #2: Yes

**********

5. Review Comments to the Author

Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters)

Reviewer #1: Thank you for the opportunity of reviewing “Childhood vaccination coverage by socioeconomic, geographic, maternal, child, and healthcare characteristics in Nigeria: equity impact analysis” . The study involved 6,059 children (12-23 months old), where the data are based from the 2018 Nigeria Demographic and Health Survey. The study revealed that, in Nigeria, the basic vaccination coverage reached 31% (95% CI: 29–33), while 19% (95% CI:18–21) of children aged 12-23 months had received no basic vaccines. Determinants such as household wealth, religion, and ethnicity, region and place of residence, maternal age at birth, maternal education, and maternal household head status, sex of child, and birth order, antenatal care, and birth setting. Several comments:

1. I find this manuscript being hard to read. The structure is confusing and hard to follow.

2. Abstract is lack of quantitative results. Please state the number instead of what have been calculated.

3. I don’t understand the term ‘equity’ the author put in the title. Why the study is different to other study who report the determinants of vaccine coverage?

4. Please add “Study design” section in the “Methods”. Also, please disclose the time of the study therein.

5. Please improve the table presentation.

6. The figures are not well organized.

7. In introduction, please highlight the urgency of this study reporting the data from a low-income country. A previous study has hinted that the low- and middle-income countries suffer the most from the lack of vaccine coverage (https://narraj.org/main/article/view/57 and others).

8. I understand that the study was based on 2018 survey. But, could you give a comment on how the current pandemic could further hamper the vaccination inequity. (refer to: https://narraj.org/main/article/view/7 or https://doi.org/10.7189%2Fjogh.11.03086)

Reviewer #2: As the issue of vaccine inequity in low- and middle-income countries is still one of public health concerns, I think this paper is very interesting and important.

The authors have done a wonderful job by clearly stating the aim of the study, the significance as well as the importance of this research. The methods section was presented clearly, so that it was easy to follow each step of the investigation. The results were presented in an intangible manner, and the discussion covers all important findings in the study. Well done!

However, there is one thing I would like to clarify. In the results section, line 220-222, it was written that “Vaccination cards were available for 49% (46-51%) of children, among which 57% (55-60%) had received all basic vaccinations. Among the 51% (49-54%) of children without vaccination cards, only 6.4% (5.3-7.7%) of them had received all basic vaccinations.”

My question is, at what age does the complete vaccination program should be accomplished? As the population of this study was children aged 12-23 months, there might be possibility that children who have not received all basic vaccinations were younger than the cut off for complete vaccination (explaining why they have not completed all basic vaccinations). How will the authors explain this result?

Above all, I think the authors have done an incredible job in presenting such important study, which helpfully will positively contribute to better vaccination coverage in Nigeria.

**********

6. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files.

If you choose “no”, your identity will remain anonymous but your review may still be made public.

Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy.

Reviewer #1: No

Reviewer #2: Yes: Amanda Yufika, MD, MSc

**********

[NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.]

While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org. Please note that Supporting Information files do not need this step.

PLoS One. 2024 Mar 6;19(3):e0297326. doi: 10.1371/journal.pone.0297326.r002

Author response to Decision Letter 0


14 May 2023

Response to Academic Editor comments

1. Comment: Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming. The PLOS ONE style templates can be found at

https://journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf and

https://journals.plos.org/plosone/s/file?id=ba62/PLOSOne_formatting_sample_title_authors_affiliations.pdf

Response: The manuscript has been updated to follow the PLOS ONE’s style requirements.

2. Comment: Please provide an amended statement that declares *all* the funding or sources of support (whether external or internal to your organization) received during this study, as detailed online in our guide for authors at http://journals.plos.org/plosone/s/submit-now.

Response: We have updated the funding statement

KA is supported by the Vaccine Impact Modelling Consortium (OPP1157270). There was no additional external funding received for this study. The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.

3. Comment: Your ethics statement should only appear in the Methods section of your manuscript.

Response: We have moved the ethics statement to the Methods section

4. Comment: We note that Figure 4 in your submission contains a map image which may be copyrighted. We require you to either (1) present written permission from the copyright holder to publish these figures specifically under the CC BY 4.0 license, or (2) remove the figures from your submission

Response: This figure has been redrawn using RStudio and naijR package using data from the CIA World Factbook. The figure caption has been updated as below:

(The figure is created by the authors using RStudio and naijR package using data from CIA World Factbook. The figure can be reproduced under CC BY 4.0 license)

5. Comment: Please include captions for your Supporting Information files at the end of your manuscript, and update any in-text citations to match accordingly. Please see our Supporting Information guidelines for more information: http://journals.plos.org/plosone/s/supporting-information.

Response: We have updated the captions and in-text citations

Response to Reviewer Comments

Reviewer #1

● Comment: Thank you for the opportunity of reviewing “Childhood vaccination coverage by socioeconomic, geographic, maternal, child, and healthcare characteristics in Nigeria: equity impact analysis” . The study involved 6,059 children (12-23 months old), where the data are based from the 2018 Nigeria Demographic and Health Survey. The study revealed that, in Nigeria, the basic vaccination coverage reached 31% (95% CI: 29–33), while 19% (95% CI:18–21) of children aged 12-23 months had received no basic vaccines. Determinants such as household wealth, religion, and ethnicity, region and place of residence, maternal age at birth, maternal education, and maternal household head status, sex of child, and birth order, antenatal care, and birth setting. Several comments:

Response: We thank you for your valuable feedback. We have updated the manuscript to address your comments, and the updates in the paper are highlighted with yellow background colour.

1. Comment: I find this manuscript being hard to read. The structure is confusing and hard to follow.

Response: We have updated the paper to improved the readability.

2. Comment: Abstract is lack of quantitative results. Please state the number instead of what have been calculated.

Response: We have added quantitative results of adjusted odds ratios to the Abstract as follows:

Results: From the systematic review, we identified the key determinants of immunisation to be household wealth, religion, and ethnicity for socioeconomic characteristics; region and place of residence for geographic characteristics, maternal age at birth, maternal education, and household head status for maternal characteristics; sex of child and birth order for child characteristics; and antenatal care and birth setting for healthcare characteristics. Based on the 2018 Nigeria DHS analysis of 6,059 children aged 12-23 months, we estimated that basic vaccination coverage was 31% (95% CI: 29–33) among children aged 12-23 months, whilst 19% (95% CI:18–21) of them were zero-dose children who had received none of the basic vaccines. After controlling for background characteristics, there was a significant increase in the odds of basic vaccination by household wealth (AOR: 3.21 (2.06, 5.00), p 0.001) for the wealthiest quintile compared to the poorest quintile, antenatal care of four or more antenatal care visits compared to no antenatal care (AOR: 2.87 (2.21, 3.72), p 0.001), delivery in a health facility compared to home births (AOR 1.32 (1.08, 1.61), p = 0.006), relatively older maternal age of 35-49 years compared to 15-19 years (AOR: 2.25 (1.46, 3.49), p 0.001), and maternal education of secondary or higher education compared to no formal education (AOR: 1.79 (1.39, 2.31), p 0.001). Children of Fulani ethnicity in comparison to children of Igbo ethnicity had lower odds of receiving basic vaccinations (AOR: 0.51 (0.26, 0.97), p = 0.039).

3. Comment: I don’t understand the term ‘equity’ the author put in the title. Why the study is different to other study who report the determinants of vaccine coverage?

Response: In the fourth paragraph of Introduction section, we have explained why we refer to inequity rather than inequality.

We refer to vaccine inequity as unfair and avoidable or remediable differences in health among population groups defined socially, economically, demographically, or geographically [21]. This is related to but distinct from health inequality, which indicates the status of imbalances or differences in health among population groups without any moral judgement on whether the imbalances or differences are fair or not [22,23].

4. Comment: Please add “Study design” section in the “Methods”. Also, please disclose the time of the study therein.

Response: We have updated the title of the below section in the Methods which states the study time – “We analysed the 2018 Nigeria DHS which was conducted between August to December 2018 [74]. “

Study design of demographic and health survey

We analysed the 2018 Nigeria DHS which was conducted between August to December 2018 [74]. The DHS are nationally representative household surveys focusing on population, health, and nutrition in LMICs [75]. The DHS sample is a two-stage stratified cluster sample with sampling weights applied to ensure that results are representative. There are four questionnaires: household questionnaire, woman’s questionnaire, man’s questionnaire, and biomarker questionnaire. The country is divided into clusters with 30 households selected from each cluster. The woman’s questionnaire was asked to women aged 15-49 years and provides the data for our study. All women aged 15-49 years in the sampled households were included and the survey was successfully conducted in 1,389 clusters after 11 clusters were dropped following deteriorating security in those areas during data collection. In addition, in the state of Borno, 11 of the 27 Local Government Areas (LGAs) in the state were dropped due to insecurity. Clusters selected from these dropped LGAs were replaced with clusters from the remaining LGAs and so may not be representative of the entire state [74]. The study population for our analysis was women aged 15-49 years with a child aged 12 to 23 months old. Of the 41,821 women interviewed, 33,924 women had a child aged 59 months or younger and immunisation data was collected for 6,059 living children aged between 12-23 months. We applied sampling weights to the survey dataset to adjust for disproportionate sampling and non-response, thereby ensuring that the sample was representative of the population.

5. Comment: Please improve the table presentation.

Response: Thank you – we have presented the table with all the required information and this will be formatted as per the journal’s requirements during typesetting.

6. Comment: The figures are not well organized.

Response: We have uploaded high-resolution figures as separate file. The figures will be organised as per the journal’s requirements during typesetting.

7. Comment: In introduction, please highlight the urgency of this study reporting the data from a low-income country. A previous study has hinted that the low- and middle-income countries suffer the most from the lack of vaccine coverage (https://narraj.org/main/article/view/57 and others).

Response: The third paragraph in the Introduction includes information that Nigeria has the most under-immunised children in the world with 4.5 million in 2018, highlighting the immunisation system challenges. We have updated this to include the immunisation challenges from COVID-19 and have referenced the study from comment 8 in the third paragraph in the Introduction section: https://narraj.org/main/article/view/7.

This study was included out of context – Hassan W, Kazmi SK, Tahir MJ, Ullah I, Royan HA, Fahriani M, et al. Global acceptance and hesitancy of COVID-19 vaccination: A narrative review. Narra J. 2021;1. doi:10.52225/narra.v1i3.57.

The Expanded Programme on Immunisation (EPI) was established by the World Health Organization (WHO) in 1974 to improve vaccination services globally [12], and Nigeria began nationwide implementation of EPI in 1979 which was later changed to the National Programme on Immunization [13]. Although the vaccines in the routine immunisation programme (Table S1) for under 5-year-old children are available with no out-of-pocket charges [14], Nigeria has the most under-immunised children in the world with 4.5 million in 2018 [15]. The immunisation system challenges in Nigeria include weak institutions, service delivery, funding, infrastructure, poor coordination between the National Programme on Immunization and non-governmental organisations delivering vaccination services, and a lack of political commitment in some regions, with further challenges to immunisation services caused by the COVID-19 pandemic [14,16–18]. There are fewer adequately skilled healthcare personnel in rural areas and northern states, and poor retention and frequent transfers of workers. Security is also an issue, with attacks on healthcare workers in recent years. Attitudes of communities and caregivers are important too, with a lack of knowledge about vaccination and mistrust of services hindering vaccination uptake [16,19].

8. Comment: I understand that the study was based on 2018 survey. But, could you give a comment on how the current pandemic could further hamper the vaccination inequity. (refer to: https://narraj.org/main/article/view/7 or https://doi.org/10.7189%2Fjogh.11.03086)

Response: The ninth paragraph in the Discussion section highlights the COVID-19 disruption on routine immunisation. The two references are now included in this paragraph.

Our estimates of vaccination coverage in Nigeria for 2018 were lower than national estimates based on administrative reporting from health service providers, though closer to WHO and UNICEF Estimates of National Immunization Coverage (WEUNIC) (see Appendix S5) [92]. The coverage gaps have been shown to be systematically underestimated by administrative reporting in Nigeria [93]. In 80% of Nigerian states, the basic vaccination coverage was below the national target of 95% or higher coverage and below the Gavi target of 90% DTP3 coverage [94]. The below target coverage for first doses indicates challenges with access to immunisation services while the decrease in coverage for subsequent doses indicates drop-out due to insufficient knowledge on dose completion [9,95,96]. The COVID-19 pandemic has disrupted vaccination globally and coverage was lower than expected in Nigeria in 2020 [17,18,97], highlighting the urgent need for catch-up vaccination to close the immunity gaps and prevent vaccine-preventable disease outbreaks [98]. The role of conflict on these disparities is also important to understand. A literature review of conflict and vaccination inferred that conflict-affected countries had vaccination coverage below global levels and conflict affected vaccination services and human resources, including attacks on healthcare workers, which has happened in Nigeria [14,64]. Our study inferences complement the findings in related studies in Nigeria and other countries (see Table 1).

Reviewer #2

● Comment: As the issue of vaccine inequity in low- and middle-income countries is still one of public health concerns, I think this paper is very interesting and important.

The authors have done a wonderful job by clearly stating the aim of the study, the significance as well as the importance of this research. The methods section was presented clearly, so that it was easy to follow each step of the investigation. The results were presented in an intangible manner, and the discussion covers all important findings in the study. Well done!

○ Response: We thank you for your valuable feedback. We have updated the manuscript to address your comments, and the updates in the paper are highlighted with yellow background colour.

● Comment: However, there is one thing I would like to clarify. In the results section, line 220-222, it was written that “Vaccination cards were available for 49% (46-51%) of children, among which 57% (55-60%) had received all basic vaccinations. Among the 51% (49-54%) of children without vaccination cards, only 6.4% (5.3-7.7%) of them had received all basic vaccinations.”

My question is, at what age does the complete vaccination program should be accomplished? As the population of this study was children aged 12-23 months, there might be possibility that children who have not received all basic vaccinations were younger than the cut off for complete vaccination (explaining why they have not completed all basic vaccinations). How will the authors explain this result?

○ Response: The routine vaccinations in Nigeria are listed in S1 Table in the appendix. By 9 months children should have received all of their basic vaccinations and so children included in the study (aged 12-23 months) should have received all of their basic vaccinations by this age.

● Comment: Above all, I think the authors have done an incredible job in presenting such important study, which helpfully will positively contribute to better vaccination coverage in Nigeria.

○ Response: Thank you for your valuable feedback.

Attachment

Submitted filename: Response_to_Reviewer_Comments.docx

pone.0297326.s007.docx (25.5KB, docx)

Decision Letter 1

Harapan Harapan

6 Jun 2023

PONE-D-23-02804R1Childhood vaccination coverage by socioeconomic, geographic, maternal, child, and healthcare characteristics in Nigeria: equity impact analysisPLOS ONE

Dear Dr. Williams,

Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process.

Please submit your revised manuscript by Jul 21 2023 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file.

Please include the following items when submitting your revised manuscript:

  • A rebuttal letter that responds to each point raised by the academic editor and reviewer(s). You should upload this letter as a separate file labeled 'Response to Reviewers'.

  • A marked-up copy of your manuscript that highlights changes made to the original version. You should upload this as a separate file labeled 'Revised Manuscript with Track Changes'.

  • An unmarked version of your revised paper without tracked changes. You should upload this as a separate file labeled 'Manuscript'.

If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter.

If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: https://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols. Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-emailutm_source=authorlettersutm_campaign=protocols.

We look forward to receiving your revised manuscript.

Kind regards,

Harapan Harapan, MD, PhD

Academic Editor

PLOS ONE

Journal Requirements:

Please review your reference list to ensure that it is complete and correct. If you have cited papers that have been retracted, please include the rationale for doing so in the manuscript text, or remove these references and replace them with relevant current references. Any changes to the reference list should be mentioned in the rebuttal letter that accompanies your revised manuscript. If you need to cite a retracted article, indicate the article’s retracted status in the References list and also include a citation and full reference for the retraction notice.

[Note: HTML markup is below. Please do not edit.]

Reviewers' comments:

Reviewer's Responses to Questions

Comments to the Author

1. If the authors have adequately addressed your comments raised in a previous round of review and you feel that this manuscript is now acceptable for publication, you may indicate that here to bypass the “Comments to the Author” section, enter your conflict of interest statement in the “Confidential to Editor” section, and submit your "Accept" recommendation.

Reviewer #1: (No Response)

Reviewer #2: All comments have been addressed

**********

2. Is the manuscript technically sound, and do the data support the conclusions?

The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented.

Reviewer #1: Yes

Reviewer #2: Yes

**********

3. Has the statistical analysis been performed appropriately and rigorously?

Reviewer #1: Yes

Reviewer #2: Yes

**********

4. Have the authors made all data underlying the findings in their manuscript fully available?

The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified.

Reviewer #1: Yes

Reviewer #2: Yes

**********

5. Is the manuscript presented in an intelligible fashion and written in standard English?

PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here.

Reviewer #1: Yes

Reviewer #2: Yes

**********

6. Review Comments to the Author

Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters)

Reviewer #1: There are some minor and technical issues left. Please find them below:

1. Thank you for the clarification regarding “inequality”. Nonetheless, I still could not see what is new from this study. In introduction. please tell explicitly what have been performed in the past studies, and what is new in this present study.

2. Study design should be put before the “Characteristics selection and systematic review”. The section details why systematic review performed and how the information is used in the following study. This section will ease reader to understand the general overview of the methods before going deeper to details.`

3. Consider to move Table 1 to results.

4. In tables. “Probability” do you mean p-value? Also please define all abbreviation in table footnote including “DTP-HepB-Hib” and many others.

5. Table 3. Some values were written in bold – not sure why. Please explain why they were presented in bold in table footnote.

Reviewer #2: I would like to thank the authors for addressing my comments. No more comments or suggestions from me. All the best with the manuscript.

**********

7. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files.

If you choose “no”, your identity will remain anonymous but your review may still be made public.

Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy.

Reviewer #1: No

Reviewer #2: No

**********

[NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.]

While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org. Please note that Supporting Information files do not need this step.

PLoS One. 2024 Mar 6;19(3):e0297326. doi: 10.1371/journal.pone.0297326.r004

Author response to Decision Letter 1


19 Jun 2023

Second revision (June 6, 2023)

Response to Reviewer Comments

Reviewer #1

● Comment: There are some minor and technical issues left. Please find them below:

Response: We thank you for your valuable feedback. We have updated the manuscript to address your comments, and the updates in the paper are highlighted with yellow background colour.

1. Comment: Thank you for the clarification regarding “inequality”. Nonetheless, I still could not see what is new from this study. In introduction. please tell explicitly what have been performed in the past studies, and what is new in this present study.

Response:

● At the end of Introduction section, we have added the sentence – “We conducted disaggregated equity impact analysis to reveal the inequities in basic vaccination coverage that are hidden at the aggregated national level, and understand the facilitators and barriers to vaccination through the social determinants of health framework. ”

● Throughout the Discussion section, we highlight the reasons for the inferences from our analysis with supporting evidence from related studies in Nigeria and other countries as applicable. However, this differentiates our study because in addition to identifying characteristics associated with basic vaccination coverage, we highlight the facilitators and barriers faced by different social subgroups specifically in the Nigerian context.

2. Comment: Study design should be put before the “Characteristics selection and systematic review”. The section details why systematic review performed and how the information is used in the following study. This section will ease reader to understand the general overview of the methods before going deeper to details.`

Response: We have moved the subsection “Study design of demographic and health survey” before the subsection “Characteristics selection and systematic review”.

3. Comment: Consider to move Table 1 to results.

Response: We have moved Table 1 to results.

4. Comment: In tables. “Probability” do you mean p-value? Also please define all abbreviation in table footnote including “DTP-HepB-Hib” and many others.

Response:

● Yes, “Probability” mean p-value. We have replaced “probablity” with “p-value” in Table 2 column header.

● We have added the footnote to tables – BCG refers to Bacille Calmette-Guérin and DTP-HepB-Hib refers to diphtheria, tetanus, pertussis (DTP), hepatitis B (HepB) and Haemophilus Influenzae type b (Hib).

5. Comment: Some values were written in bold – not sure why. Please explain why they were presented in bold in table footnote.

Response:

● We have added a note at the bottom of Table 3 – Bold values represent the statistically significant results.

Attachment

Submitted filename: Response to reviewers.docx

pone.0297326.s008.docx (18.3KB, docx)

Decision Letter 2

Harapan Harapan

27 Oct 2023

PONE-D-23-02804R2Childhood vaccination coverage by socioeconomic, geographic, maternal, child, and healthcare characteristics in Nigeria: equity impact analysisPLOS ONE

Dear Dr. Williams,

Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process.

Please submit your revised manuscript by Dec 11 2023 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file.

Please include the following items when submitting your revised manuscript:

  • A rebuttal letter that responds to each point raised by the academic editor and reviewer(s). You should upload this letter as a separate file labeled 'Response to Reviewers'.

  • A marked-up copy of your manuscript that highlights changes made to the original version. You should upload this as a separate file labeled 'Revised Manuscript with Track Changes'.

  • An unmarked version of your revised paper without tracked changes. You should upload this as a separate file labeled 'Manuscript'.

If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter.

If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: https://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols. Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-emailutm_source=authorlettersutm_campaign=protocols.

We look forward to receiving your revised manuscript.

Kind regards,

Steve Zimmerman, PhD

Senior Editor, PLOS ONE

on behalf of

Harapan Harapan, MD, PhD

Academic Editor

PLOS ONE

Journal Requirements:

Please review your reference list to ensure that it is complete and correct. If you have cited papers that have been retracted, please include the rationale for doing so in the manuscript text, or remove these references and replace them with relevant current references. Any changes to the reference list should be mentioned in the rebuttal letter that accompanies your revised manuscript. If you need to cite a retracted article, indicate the article’s retracted status in the References list and also include a citation and full reference for the retraction notice.

Additional Editor Comments:

Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has satisfied our scientific requirements for publication.

However, we also note that this manuscript contains a systematic review; our author guidelines require that you upload a PRISMA checklist as supporting information (https://journals.plos.org/globalpublichealth/s/submission-guidelines#loc-systematic-reviews-and-meta-analyses). Information about the PRISMA guidance and blank checklists can be found here: http://www.prisma-statement.org/.

Please could you resubmit with a completed copy of the PRISMA checklist as a "Supporting Information" file?

[Note: HTML markup is below. Please do not edit.]

[NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.]

While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org. Please note that Supporting Information files do not need this step.

PLoS One. 2024 Mar 6;19(3):e0297326. doi: 10.1371/journal.pone.0297326.r006

Author response to Decision Letter 2


13 Dec 2023

We have submitted a PRISMA checklist as a supporting information file and alongside this we would like to revise the title of the manuscript to, “Systematic review of social determinants of childhood immunisation in low- and middle-income countries and equity impact analysis of childhood vaccination coverage in Nigeria” so that readers are aware that it is a systematic review. We have updated the manuscript with changes tracked.

Decision Letter 3

Harapan Harapan

4 Jan 2024

Systematic review of social determinants of childhood immunisation in low- and middle- income countries and equity impact analysis of childhood vaccination coverage in Nigeria

PONE-D-23-02804R3

Dear Dr. Williams,

We’re pleased to inform you that your manuscript has been judged scientifically suitable for publication and will be formally accepted for publication once it meets all outstanding technical requirements.

Within one week, you’ll receive an e-mail detailing the required amendments. When these have been addressed, you’ll receive a formal acceptance letter and your manuscript will be scheduled for publication.

An invoice for payment will follow shortly after the formal acceptance. To ensure an efficient process, please log into Editorial Manager at http://www.editorialmanager.com/pone/, click the 'Update My Information' link at the top of the page, and double check that your user information is up-to-date. If you have any billing related questions, please contact our Author Billing department directly at authorbilling@plos.org.

If your institution or institutions have a press office, please notify them about your upcoming paper to help maximize its impact. If they’ll be preparing press materials, please inform our press team as soon as possible -- no later than 48 hours after receiving the formal acceptance. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org.

Kind regards,

Harapan Harapan, MD, PhD

Academic Editor

PLOS ONE

Additional Editor Comments (optional):

Reviewers' comments:

Acceptance letter

Harapan Harapan

27 Feb 2024

PONE-D-23-02804R3

PLOS ONE

Dear Dr. Williams,

I'm pleased to inform you that your manuscript has been deemed suitable for publication in PLOS ONE. Congratulations! Your manuscript is now being handed over to our production team.

At this stage, our production department will prepare your paper for publication. This includes ensuring the following:

* All references, tables, and figures are properly cited

* All relevant supporting information is included in the manuscript submission,

* There are no issues that prevent the paper from being properly typeset

If revisions are needed, the production department will contact you directly to resolve them. If no revisions are needed, you will receive an email when the publication date has been set. At this time, we do not offer pre-publication proofs to authors during production of the accepted work. Please keep in mind that we are working through a large volume of accepted articles, so please give us a few weeks to review your paper and let you know the next and final steps.

Lastly, if your institution or institutions have a press office, please let them know about your upcoming paper now to help maximize its impact. If they'll be preparing press materials, please inform our press team within the next 48 hours. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org.

If we can help with anything else, please email us at customercare@plos.org.

Thank you for submitting your work to PLOS ONE and supporting open access.

Kind regards,

PLOS ONE Editorial Office Staff

on behalf of

Dr. Harapan Harapan

Academic Editor

PLOS ONE

Associated Data

    This section collects any data citations, data availability statements, or supplementary materials included in this article.

    Supplementary Materials

    S1 Checklist. PRISMA checklist.

    (DOCX)

    pone.0297326.s001.docx (32.8KB, docx)
    S1 Table. Routine vaccination schedule of under 1-year-old children in Nigeria.

    (DOCX)

    pone.0297326.s002.docx (13KB, docx)
    S2 Table. Vaccination coverage and vaccination card usage rates in Nigeria.

    (DOCX)

    pone.0297326.s003.docx (15.2KB, docx)
    S3 Table. Interaction effects.

    (DOCX)

    pone.0297326.s004.docx (24.1KB, docx)
    S4 Table. Vaccine coverage.

    Vaccine coverage estimates for Nigeria in 2018 based on DHS, WUENIC (WHO-UNICEF), administrative, and official country sources.

    (DOCX)

    pone.0297326.s005.docx (13.2KB, docx)
    S1 Fig. PRISMA flowchart.

    The Preferred Reporting Items for Systematic Reviews and Meta Analyses (PRISMA) flow diagram of articles’ identification, screening, eligibility, and inclusion in the systematic review is illustrated.

    (DOCX)

    pone.0297326.s006.docx (27.1KB, docx)
    Attachment

    Submitted filename: Response_to_Reviewer_Comments.docx

    pone.0297326.s007.docx (25.5KB, docx)
    Attachment

    Submitted filename: Response to reviewers.docx

    pone.0297326.s008.docx (18.3KB, docx)

    Data Availability Statement

    The 2018 Nigeria DHS data set is publicly available and accessible upon registration for legitimate research purposes on the DHS website at https://dhsprogram.com/methodology/survey/survey-display-528.cfm. To download DHS datasets, researchers must register as a DHS data user at https://dhsprogram.com/data/new-user-registration.cfm.


    Articles from PLOS ONE are provided here courtesy of PLOS

    RESOURCES